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Smoking and High-Fat Diet:  
Risk Factors Regulating Emphysema Formation 
Polina Golovatch 
 
Emphysema is a complex pathology characterized by the progressive enlargement 
of airspaces and the destruction of alveolar walls. Multiple environmental and genetic 
risk factors influence the initiation and progression of this disease. Cigarette smoke has 
been known for a long time to be the major contributor to the development of 
emphysema. However, a possible impact of hypercholesterolemia on the destruction of 
alveoli has not been investigated. The work presented in this thesis identifies the role of 
hypercholesterolemia in the development of emphysema. It also elucidates new 
molecular mechanisms leading to the proteolytic destruction of lung tissue, secondary to 
cigarette smoke exposure or to a high-fat diet.  
The study reported in chapter two explores the effect of cigarette smoke on the 
pulmonary inflammation and proteolytic response leading to the development of 
emphysema in guinea pigs. For the first time, we demonstrated that smoke-induced 
expression of Cathepsin K in the lungs contributes to the degradation of the extracellular 
matrix, ultimately resulting in emphysema. Studies in chapters three and four show that 
hypercholesterolemia is an important risk factor for pulmonary emphysema. These 
studies discuss the role of MAP kinases, Toll-like signaling, ceramide signaling and 
proteolytic enzymes in the pathogenesis of emphysema resulting from chronic smoke 
exposure or from an atherogenic diet. Data obtained with a rabbit model of emphysema 
further demonstrate that matrix metalloproteinase-1 (MMP-1) likely plays a key role in 
the pathological degradation of the lung extracellular matrix. 
Together, the studies presented in this thesis indicate that, in addition to cigarette 
smoking, hypercholesterolemia may be an important risk factor in the development of 
human emphysema and provide novel insights into the molecular mechanisms leading to 
pulmonary inflammation and alveolar destruction.  In addition, our work further 
illustrates the crucial role of proteases in the development of emphysema and offer novel 
therapeutic targets for the treatment of this disease.  
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Glossary 
 
Alveoli – the final branchings of the respiratory tree that act as the primary gas exchange 
units of the lung. 
 
Alveolar type I cells – epithelial cells that have long cytoplasmic extensions, which 
spread along the alveolar walls and comprise the thin alveolar epithelium.  
 
Alveolar type II cells – epithelial cells of cuboidal shape that are responsible for 
producing surfactant that reduces surface tension throughout the lung. 
 
Antioxidants – molecules that are capable of inhibiting the oxidation of other molecules. 
Antioxidants remove free radical intermediates and inhibit other oxidation reactions. 
They neutralize free radicals by donating one of their own electrons. 
 
Apolipoprotein E – a ligand that mediates uptake of VLDL particles and chylomicron 
remnants by the liver and peripheral cells. It is involved in the normal catabolism of 
triglyceride-rich lipoprotein constituents. 
 
Apoptosis – process of programmed cell death. During apoptosis, cells die in a controlled 
and regulated fashion. Apoptosis is different from necrosis, which is an uncontrolled cell 
death leading to lysis of the cells. 
 
Atherosclerosis – a condition in which deposits of fatty substances, cholesterol, and 
cellular waste products accumulate in the inner lining of an artery forming a plaque. 
 
Caspases – cysteine proteases involved in the regulation and execution of apoptosis. They 
are predominantly localized in the cytoplasm of the cells. 
 
Cathepsins – proteolytic enzymes that degrade proteins of the extracellular matrix in 
addition to their role in protein turnover. 
 
Ceramide – a lipid molecule, which is composed of sphingosine and a fatty acid and has 
been shown to contribute to the pathogenesis of emphysema. 
 
Chronic obstructive pulmonary disease – the co-occurrence of chronic bronchitis and 
emphysema, a pair of commonly co-existing diseases of the lungs in which the airways 
become narrowed. 
 
Chylomicron remnants – metabolic products of chylomicron particles, in which 
triglycerides are removed by the lipoprotein lipase. These remnants carry dietary lipids in 
the blood and are cholesterol-rich. 
 
Collagen – fibrous protein and the major component of connective tissue, cartilage and 
bone. 
 
  xii 
Collagenases – proteolytic enzymes that are capable of degrading triple-helical fibrillar 
collagens into distinctive 3/4 and 1/4 fragments. 
 
Cysteine proteases – proteases that have a common catalytic mechanism that involves a 
cysteine sulfhydryl group. They have been found in viruses, bacteria, plants and 
mammals. They function as lysosomal mediators of terminal protein degradation, 
participate in apoptosis, immune responses, and extracellular matrix remodeling. 
 
Destructive index analysis – a microscopic point count technique that determines the 
degree of lung parenchymal destruction. This analysis is performed using a transparent 
sheet with 50 counting points laid on the microscopic images from the stained lung 
sections. 
 
Extracellular matrix – the extracellular part of the tissue that provides structural support 
to the cells, segregates tissues from one another, and regulates intercellular 
communication. 
 
Emphysema – progressive disease of the lungs that causes shortness of breath. It is 
characterized by the destruction of lung tissue, which is necessary to support the physical 
shape and function of the lungs. It is often caused by smoking.  
 
Free radicals – highly reactive chemicals that contain oxygen and are released when 
molecules split to give products with unpaired electrons. Free radicals can damage 
important cellular molecules such as DNA, lipids or other parts of the cell. 
 
Gelatinases – protelytic enzymes that are capable of degrading type IV collagen and 
gelatin. 
 
High density lipoprotein – a complex of lipids and proteins that functions as a transporter 
of cholesterol in the blood. High levels are associated with a decreased risk of 
atherosclerosis. 
 
Hypercholesterolemia – the presence of high levels of cholesterol in the blood. It is 
associated with the risk of atherosclerosis. 
 
Low density lipoprotein – a complex of lipids and proteins, with greater amounts of lipid 
than protein, that transports cholesterol in the blood. High levels are associated with an 
increased risk of atherosclerosis. 
 
LDL receptor – a cell-surface receptor that mediates the endocytosis of LDL particles and 
recognizes the apoprotein B100, which is located in the phospholipid layer of LDL 
particles, and the apolipoprotein E, which is found in chylomicron and VLDL remnants. 
 
Lymphocytes – white blood cells (leukocytes) determine the specificity of the immune 
response to infectious microorganisms and other foreign substances. They bind to 
antigens (foreign substances) through receptor molecules on their surfaces and remove 
  xiii 
them from the body. These inflammatory cells are present in many pathological 
conditions. 
 
Macrophages – white blood cells that are differentiated from monocytes in tissues and 
play an important role in the pulmonary inflammation. Their function is to engulf and 
digest cellular debris and pathogens and stimulate other immune cells to attack infectious 
agents. 
 
Matrix metalloproteinases – family of proteases that are capable of degrading proteins of 
the extracellular matrix such as collagen and elastin. 
 
Matrix metalloproteinase-1, also known as interstitial collagenase – protease that 
degrades interstitial collagens, type I, II and III. 
 
Matrix metalloproteinase-9, also known as gelatinase B – protease that is capable of 
degrading gelatin and type IV collagen. 
 
Matrix metalloproteinase-12, also known as macrophage elastase – protease that is 
capable of degrading elastin and secreted by macrophages. 
 
Mean linear intercept – a measurement technique that evaluates enlargement of air 
spaces. The mean linear intercept represents the average size of alveoli. This analysis is 
performed using a transparent sheet with 10 horizontal and 11 vertical lines laid over the 
microscopic images from the stained lung sections. The intercepts of alveolar walls with 
these lines are counted. 
 
Neutrophils – white blood cells that are recruited to the site of injury and represent a 
hallmark of acute inflammation. After bacterial infection or environmental exposure, 
neutrophils migrate towards the site of inflammation through the blood vessels and 
interstitial tissue. Their function is to phagocytose microorganisms and foreign particles. 
Neutrophils contain a nucleus divided into 2-5 lobes. 
 
Neutrophil elastase – serine protease that is secreted by neutrophils and is capable of 
hydrolyzing elastin and other proteins. 
 
Oxidants – chemical compounds that readily transfer oxygen atoms or gain electrons in a 
redox (reduction-oxidation) chemical reaction. 
 
Oxidative stress – an imbalance between the production of reactive oxygen species and a 
biological system's ability to readily detoxify the reactive intermediates or to repair the 
resulting damage. 
 
Proteases – enzymes that hydrolyze peptide bonds. They are divided into exopeptidases 
(enzymes that act near a terminus of the polypeptide chain) and endopeptidases (enzymes 
that cleave internal peptide bonds). 
 
  xiv 
Pulmonary compliance – distensibility of the lung (elastic structure). It is defined as the 
change in volume of the lung produced by a change in pressure across the lung. It is an 
important measurement in respiratory physiology. 
 
Serine proteases – proteases in which one of the amino acids in the active site of the 
enzyme is serine. 
 
Sphingomyelinase – an enzyme that catalyzes the hydrolysis of sphingomyelin to 
ceramide and phosphocholine and is involved in sphingolipid metabolism. 
 
Surfactant – a phospholipid that lines the alveoli and serves to reduce surface tension at 
different volumes, contributing to alveolar stability. 
 
Toll-like receptors – proteins that play an essential role in the innate immune response. 
Activation of Toll-like receptor signaling through recognition of pathogen-associated 
molecular patterns leads to the activation of genes encoding for pro-inflammatory 
cytokines and chemokines. 
 
Western-type diet – atherogenic diet that is enriched in both fat and cholesterol. 
 
Very low density lipoprotein – rich in triglycerides lipoproteins that circulate through the 
bloodstream transporting triglycerides to fat and muscle tissue until the VLDL remnants 





















The last six years spent conducting research in the D’Armiento laboratory have 
been extremely rewarding. I have felt very privileged to have studied under one of the 
best experts in the field of emphysema and have grown tremendously under the 
mentoring of Dr. D’Armiento. I am also very grateful to Dr. Lemaitre who shared with 
me his knowledge and experience. He and Dr. D’Armiento were exceptional mentors and 
influenced my scientific development first as a master’s student and finally a PhD 
candidate. 
I would like to thank the past and present members of D’Armiento laboratory, 
including: Robert Foronjy, Divya Mehra, Becky Mercer, Alison Wallace, Jules Dabo, 
Asahiro Morishita, Piotr Sklepkiewicz, Takwi Nkyimbeng, Anita Sen, Leo Arelanos, 
Jincy Thankachen, Andrea Rosero, David Sternberg, Kathleen Whalen, Monica 
Goldklang. I especially thank Patrick Geraghty who has been a great help and support in 
facing and critically appraising the enormous number of research studies. I am grateful to 
Tina Zelonina for 6 years of technical assistance. I would also like to recognize Takayuki 
Shiomi and Tomoe Shiomi for excellent technical histology support. 
I would like to thank my graduate advisors and defense committee members: Drs. 
Ira Goldberg, Li-Shin Huang, Ravichandran Ramasamy, Sanja Jelic and Debra 
Wolgemuth. 





























1. Anatomy of the lungs 
The lungs play an important role in sustaining life by exchanging oxygen and 
carbon dioxide with the environment.  The right lung is divided into three lobes and the 
left lung into two lobes. The lungs are separated into a conducting and respiratory zone. 
The conducting zone contains the trachea, the bronchi, the bronchioles, and the terminal 
bronchioles and is involved in the conduction of air into the lungs. The respiratory zone is 
the site of gas exchange and contains the respiratory bronchioles, the alveolar ducts, and 
the alveoli (Bittar, 2002).  
The main functional units of the lungs are alveoli, which constitute 80 to 85% of 
the volume of normal lung (Bourbon, 1999) (Figures 1 and 2). There are two important 
cell types lining the alveoli: alveolar type I cells and alveolar type II cells. Alveolar type I 
cells are thin cells that form the main structure of the alveolar wall and enable gas 
diffusion through close contact with capillaries. Type II cells have a cuboidal shape and 
secrete pulmonary surfactant, which lowers the surface tension, and thereby prevents the 
collapse of the alveoli during expiration (Bourbon, 1999). Alveolar macrophages are 
present within the alveolar air space and alveolar wall (Figure 2). Their functions are to 
initiate immune responses and clear debris such as dust, dead cells or smoke particles 
(Sorokin et al., 1999). The capillary endothelium stretches out smoothly in one-cell-thick 
layers between the alveoli, and allows gas and fluid exchange both in and out of the 
bloodstream (Burri, 1999). In addition, endothelium filters blood clots and waste, 
moderates the action of chemicals, stores immune cells during infections and provides 




extracellular fibers. These cells include fibroblasts, myofibroblasts, smooth muscle cells, 










Figure 2. Histologic specimen of lung tissue stained with hematoxylin and eosin 
(H&E). Alveoli are lined by flattened alveolar type I cells and cuboidal alveolar type II 




Fibroblasts produce Type I, II, and III collagens and elastic fibers, the major 
constituents of the lung extracellular matrix. Fibrillar collagens (types I, II, and III) are 
the most abundant collagens in the lung, but other non-fibrillar collagens are also present. 
The primary function of fibrillar collagens is to confer tensile strength to the distensible 
components of the lung, such as the large airways, blood vessels, and the alveolar 
interstitium (Keyzer and Post, 1999).  
Type I and III collagens represent approximately 90% of all collagens in the 
human lung. These collagens are located throughout the alveolar interstitium, in the blood 
vessels, in the pleura, and around the thracheobronchial tree. Type I collagen provides 
tensile strength and rigidity, whereas type III forms a network of fibers and confers 
compliance (Keyzer and Post, 1999). Other fibrillar collagens include types II, V, and XI.  
Types II and XI are found in bronchial and tracheal cartilage, and type V is present in the 
basement membranes, interstitium, alveolar walls, and in the blood vessels (Keyzer and 
Post, 1999).  
Type IV is the most abundant non-fibrillar collagen of the lung (Hudson et al., 
1993). Contrary to fibrillar collagens, type IV collagen molecules form network 
structures resulting from a lateral association of their amino- and carboxy-terminal 
regions. These networks of type IV collagen are critical for the barrier functions of the 
basement membrane (Gaillard and Puchelle, 1999). This collagen is also responsible for 
the tensile strength of the blood-gas barrier and prevents stress failure of the pulmonary 
capillaries (Gaillard and Puchelle, 1999). Other non-fibrillar collagens present in the lung 
include type VI (in the interstitium and vessels), type VIII (in arterioles), and types IX, 




Elastin, another major component of the lung extracellular matrix, is composed of 
insoluble flexible cross-linked polypeptides, organized into easily extensible fibers 
(Fung, 1993). The elastic fibers exhibit significant structural heterogeneity and are also 
known to be mechanically connected to the collagen (Brown et al., 1994) via microfibrils 




2. Chronic obstructive pulmonary disease (COPD) and emphysema 
Chronic obstructive pulmonary disease (COPD) is one of the major global health 
problems. It represents the third leading cause of death in the United States as reported by 
the Centers for Disease Control and Prevention (Miniño, 2010). Currently COPD affects 
more than twelve million Americans (Krishnan, 2010). However, lung function tests 
indicate that nearly 24 million US citizens may have the disease, suggesting an 
underdiagnosis of COPD (Blanchette, 2011). According to the National Health Interview 
Survey (NHIS), the prevalence rate and the overall age-adjusted death rate for COPD is 
higher in the female population (Bang, Syamlal, & Mazurek, 2009). Additionally, 
socioeconomic status, as measured by the level of education and income, affects 
morbidity and mortality rates (Prescott, Lange, & Vestbo, 1999). COPD is a costly 
condition to treat and it was estimated that the total economic burden of this disease was 
$49.9 billion in 2010 (Austin, 2010). Since the prevalence of COPD and health care costs 
are constantly increasing, the need to better understand the mechanisms of the disease is 
urgent.   
COPD is an umbrella term that primarily includes emphysema with enlargement 
of airspaces and chronic obstructive bronchitis with obstruction of small airways 
(Molfino, 2004). It is crucial for therapeutic and prognostic reasons to differentiate which 
disease state dominates in a patient. The Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) classifies COPD as a disease state characterized by airflow limitation 
that is not fully reversible and associated with an abnormal inflammatory response of the 
lungs to noxious particles and gases. The American Thoracic Society (ATS) classifies 




chronic bronchitis or emphysema; the airflow obstruction is generally progressive and 
may be partially reversible ("Standards for the diagnosis and care of patients with chronic 
obstructive pulmonary disease. American Thoracic Society," 1995). Airflow limitation is 
measured by spirometry and is identified as a reduction of expiratory flow.  
Emphysema is a chronic pulmonary condition that severely impacts quality of life 
and causes considerable morbidity in those who suffer from it (Kaplan, 2008). 
Emphysema is characterized by abnormal permanent enlargement of the airspaces distal 
to terminal bronchioles and accompanied by the destruction of alveolar walls (Vlahovic, 
Russell, Mercer, & Crapo, 1999). The first description of emphysema belongs to the 
brilliant clinician and pathologist Rene Laennec (1837). He observed that the lungs of 
diseased patients were hyperinflated and did not empty well. The invention of a simple 
spirometer helped clinicians to diagnose patients with emphysema (Hutchinson 1846) and 
one hundred years later the spirometer became a complete diagnostic tool for the 
measurement of airflow (1947). In 1944, another fundamental contributor to the 
knowledge of emphysema, Ronald Christie, described the major clinical features of the 
disease such as reduced elastic recoil and destruction of alveolar walls (Christie, 1944a, 
1944b).  
Presently emphysema is characterized by irreversible airflow limitation and is 
associated with abnormal enlargement of the airspaces distal to terminal bronchioles and 
accompanied by the destruction of alveolar walls (Vlahovic, Russell, Mercer, & Crapo, 
1999) (Figure 3). The destruction of pulmonary parenchyma is thought to result mainly 
from the damaging effects of proteolytic enzymes such as collagenases and elastases 




Shapiro, 1997), and free radicals generated within alveoli in response to noxious particles 
and gases (Rahman & MacNee, 1996). Emphysematous destruction of lung parenchyma 
decreases the elastic recoil force, which is necessary to expel air out of the lung 
(Rennard, 2006). Decreased elastic recoil of the lung causes shortness of breath, which is 
a common symptom among emphysema patients. Over time, the pathological changes of 
the lungs, such as the destruction of lung parenchyma, the loss of tissue collagen and 
elastin, and enlargement of alveolar airspaces may lead to the development of more 
advanced forms of emphysema (Suki et al., 2003). Current treatment options for COPD 
are limited to inhaled bronchodilators or oral corticosteroids (Niewoehner, 2010). These 
therapeutics can alleviate the symptoms of emphysema including breathlessness 
(dyspnea), wheezing, coughing and excessive mucus production, but cannot reduce the 
disease progression. People with the advanced form of emphysema are provided with 
surgical options such as lung volume reduction surgery or transplantation (Berger et al., 
2010). However, these surgeries cannot guarantee a better quality of life for patients 
(Berger et al., 2010). 
 
 
Figure 3. H&E stained lungs with normal architecture (A) and with emphysema (B).  




2. Classification of COPD 
COPD incorporates many complex and often overlapping respiratory conditions 
that develop progressively. COPD includes patients with chronic bronchitis, emphysema 
and a subset of patients with asthma (Mannino, 2002). Airflow obstruction as a common 
characteristic of COPD always should be confirmed by spirometry to avoid misdiagnosis 
(Holleman & Simel, 1995). The most current classification of the stage and severity of 
COPD is based on the level of airflow obstruction (Table 1). Airflow obstruction is 
defined as a ratio of postbronchodilator FEV1 (forced expiratory volume in one second) 
to FVC (forced volume vital capacity) of less than 0.70. However, spirometry is crucial 
for the diagnosis of COPD (Niewoehner, 2010). Other clinical methods evaluating the 
frequency of exacerbations and the intensity of breathlessness are required for the 
accurate interpretation of COPD (Mahler & Wells, 1988; Niewoehner et al., 2007). 
 
Table 1. Classification of COPD. Adapted from Niewoehner DE, 2010.  
 
Stage and Severity of COPD Definition 
Stage 1 – mild FEV1:FVC<0.70, FEV1>80% of predicted 
value 
Stage 2 – moderate FEV1:FVC<0.70, FEV1 50 to 79% of 
predicted value 
Stage 3 – severe FEV1:FVC<0.70, FEV1 30 to 49% of 
predicted value 
Stage 4 – very severe FEV1:FVC<0.70, FEV1<30% of predicted 
value or FEV1<50% of predicted value plus 







3. Risk factors for emphysema 
Environmental or genetic risk factors may contribute to the development of 
emphysema. Environmental factors include tobacco smoking, occupational exposure, air 
pollution, socioeconomic status, diet and alcohol consumption. Genetic or acquired 
individual characteristics that may cause the development of emphysema include gender, 
genetic factors, childhood respiratory problems and familial history.  
Tobacco Smoking 
Tobacco smoking exposure accounts for 80-90% of COPD patients in the United 
States and is considered to be the primary contributing factor to the formation of 
emphysema (Sethi & Rochester, 2000). Tobacco smoke is comprised of about 5,000 
various chemical compounds and condensed tar particles (Church & Pryor, 1985). Many 
of these chemicals are powerful oxidants and inducers of an inflammatory response 
causing lung damage. Cigarette smoke can also inhibit lung repair responses, which may 
lead to tissue destruction - a defining feature of emphysema (Seagrave, 2000). Results 
from prospective studies completed in the United Kingdom over 23 years demonstrate 
that smoking increases the rate of lung function decline in both males and females 
(Kohansal et al., 2009). The study also indicates that cessation of smoking at any age 
slows the decline in lung function. Of note, the presence of respiratory impaired 
symptoms at baseline identifies a group of smokers susceptible to the development of 
airflow limitation. In addition, maternal smoking has been shown to affect the respiratory 
function in neonates and it is likely that parental smoking confers increased risk of lower 






Chronic exposure to chemical substances, fumes and dusts in the work place has 
been shown to contribute to the development of COPD. Occupational exposure to 
chemical fumes or biologically inactive dust increases the prevalence of chronic airflow 
obstruction, mortality from COPD and increases rates of decline of FEV (Becklake, 
1989; Rothenbacher et al., 1997). The health risks are elevated for miners exposed to coal 
dust, which accumulates within the lungs and causes emphysema (Attfield, 1985). 
According to the American Thoracic Society, the population risk of acquiring COPD due 
to occupational exposure is estimated at around 15% (Balmes et al., 2003). 
Air pollution 
Air pollution is believed to play a role in the development of COPD. It has been 
demonstrated that long-term exposure to air pollution is positively associated with the 
incidence of COPD (Andersen et al., 2011). Moreover, living in an urban area constitutes 
a considerable risk for the development of respiratory problems (Viegi et al., 1991). In 
addition, it has been demonstrated that people exposed to air pollution chronically or 
living in the polluted cities are shown to have a decline in lung function (Dockery et al., 
1993). 
Socioeconomic status 
A low socioeconomic level is associated with the high prevalence of chronic 
bronchitis, emphysema and increased mortality from these diseases, which indicates that 
socioeconomic factors operating from early childhood affect the risk of developing 




found to be more prevalent among those with low income, poor education, and hazardous 
work or living conditions (Rogot, Sorlie, & Johnson, 1992).  In addition, studies 
demonstrate that people with only primary and secondary education more frequently 
develop airflow limitations when compared with college graduates (Bakke, Hanoa, & 
Gulsvik, 1995).  
Diet and alcohol consumption 
The association between COPD and weight loss has been investigated for a long 
time (Donahoe & Rogers, 1990). Multiple studies have demonstrated malnutrition and 
reduced body weight in patients with COPD (Gray-Donald, Gibbons, Shapiro, Macklem, 
& Martin, 1996; Wilson, Rogers, Wright, & Anthonisen, 1989). In addition, the increased 
consumption of alcohol is correlated with lower levels of FEV1 and COPD exacerbation 
(Garshick, Segal, Worobec, Salekin, & Miller, 1989; C. C. Greene et al., 2008).  
Genetic Factors 
Alpha 1-antitrypsin (A1AT) deficiency is an autosomal recessive genetic disorder 
that leads to the abnormal production of A1AT (Gooptu, Ekeowa, & Lomas, 2009). 
A1AT deficiency is also known as an ER stress-related disease as it involves mutations 
that cause A1AT misfolding, resulting in retention of abnormal A1AT in the ER and low 
circulating levels of A1AT (C. M. Greene et al., 2008). Alpha 1-antitrypsin inhibits 
neutrophil elastase activity involved in neutrophil recruitment and destruction of 
pulmonary elastin. Therefore, the excessive activity of neutrophil elastase in the absence 
of A1AT can lead to the development of emphysema (Crystal, 1990). Smoking 
significantly enhances the development of emphysema not only in the homozygous but 




alterations such as alpha-2-macroglobulin, vitamin D binding protein and the blood 
serotype group genes are linked to a higher risk of acquiring emphysema (Sandford, 
Weir, & Pare, 1997). 
Childhood and Adulthood Respiratory Problems 
Numerous studies identify the association between childhood respiratory 
problems and reduced lung function in adulthood (Krzyzanowski, Sherrill, & Lebowitz, 
1990). It has also been demonstrated that the diseases of lower respiratory tract and 
childhood respiratory infections during the first years of life lead to the development of 






4. Pathogenesis of emphysema 
The pathogenesis of emphysema is the subject of ongoing research because many 
aspects of this disease remain poorly understood. Several pathological events have been 
implicated in the development of emphysema, including an inflammatory proteolytic 
response (Grumelli et al., 2004; Shapiro, 1995), cellular apoptosis and senescence (Sato 
et al., 2006; Tuder, Zhen et al., 2003), oxidative stress (Rahman, Morrison, Donaldson, & 
MacNee, 1996), and malnutrition (D. Massaro, Massaro, Baras, Hoffman, & Clerch, 
2004) (Figure 4). Clinical and experimental studies using animal models, together with 
an association between human emphysema and deficiency in alpha1-antitrypsin indicate 
that proteases are major contributors to the development of emphysema. Alveolar septae 
of emphysematous lungs are infiltrated by inflammatory cells, including macrophages, 
lymphocytes, and neutrophils, which are an important source of proteases (Hogg et al., 
2004).  Moreover, lung epithelial and endothelial cells have also been shown to secrete 
proteases, contributing to the destructive airspace enlargement characteristic of 
emphysema (Mercer, Kolesnikova, Sonett, & D'Armiento, 2004; Taraseviciene-Stewart 
et al., 2005). Emphysema is also typified by a loss of alveolar capillary endothelial cells, 
and therefore endothelial dysfunction could be an important event contributing to 
emphysema (Kasahara et al., 2001). Cytokines and proteases released by inflammatory 
cells, apoptosis, and inhibition of the vascular endothelial growth factor (VEGF) 
signaling have been implicated in endothelial dysfunction in the lungs (Kanazawa, 2007).  
Analysis of lung tissue sections from patients with emphysema reveal elevated apoptotic 




D'Armiento, 2005). A disruption of the balance between apoptosis and the replenishment 
of structural cells in the lung could contribute to the destruction of pulmonary tissue in 
response to cigarette smoke, leading to emphysema.   
 
 




5.  Contributing factors for emphysema development 
5.1.  Inflammation  
A large number of studies suggest that the ongoing chronic inflammatory process 
is an important characteristic of emphysema (Hogg et al., 2004; Roth, 2008). 
Pathologically, pulmonary parenchyma and airways are the major sites of inflammation 
in emphysema. A significant body of evidence indicates that the destruction of 
respiratory bronchioli and alveolar walls during emphysema is the result of massive 
inflammation in the lung (Noble & Jiang, 2006). Potentially destructive mediators of 
emphysema include proteases, cytokines, and chemokines, which attract other 
inflammatory cells to the sites of injury. The accumulation of these inflammatory 
components contributes to the lung injury present in emphysema patients (Mercer et al., 
2004; Saetta, Turato, Maestrelli, Mapp, & Fabbri, 2001).  
Macrophages are the primary cell type regulating the inflammatory response in 
the lungs and are involved in tissue destruction associated with emphysema (Shapiro & 
Senior, 1999). A careful examination of pulmonary parenchyma of emphysema patients 
indicates a 25-fold increase in the number of macrophages in the tissue and alveolar 
space (Retamales et al., 2001). Of note, macrophages are localized mainly at the sites of 
inflammation or alveolar wall destruction in lungs of patients with emphysema 
(Finkelstein, Fraser, Ghezzo, & Cosio, 1995). Upon activation by cigarette smoke, 
macrophages infiltrate into alveolar septae and release a multitude of cytokines, 
chemokines and reactive oxygen species. These inflammatory mediators, including TNF-
α, IL-8, MCP-1, orchestrate a complex inflammatory process, possibly resulting in 




proteolytic enzymes that degrade major components of the lung extracellular matrix, 
specifically collagen and elastin, and therefore are likely to be responsible for the 
development of airspace enlargement (R. E. Russell et al., 2002). These alveolar 
macrophages release matrix metalloproteinases (MMPs) including MMP-2, MMP-9 and 
MMP-12, and cathepsins K, L, and S. MMPs and cathepsins are proteolytic enzymes 
known for their potent elastolytic and collagenolytic activity (Taggart et al., 2005; 
Foronjy et al., 2001; Wolters et al., 2000).  
In addition to macrophages, neutrophils are strongly implicated in the 
pathophysiology of emphysema. Elevated numbers of activated neutrophils are found in 
bronchoalveolar lavage (BAL) fluid of patients with emphysema (Finkelstein et al., 1995; 
Lacoste et al., 1993). Clinical studies demonstrate increased concentrations of 
myeloperoxidase in the sputum of patients with emphysema, suggesting that neutrophils 
present in these lungs are activated (Keatings & Barnes, 1997; Yamamoto et al., 1997). 
Furthermore, the number of circulating neutrophils positively correlates with the decline 
in lung function, further suggesting an important role for neutrophils in human 
emphysema (Richards, Theron, Van der Merwe, & Anderson, 1989). After neutrophils 
infiltrate the airways and parenchyma, they migrate into the respiratory tract, guided by 
IL-8 and other neutrophil chemotactic factors. The chemotactic molecules known for 
their potential for neutrophil recruitment and activation include CXC chemokines, MIP-
1α, MIP-1β, and MIP-2 (Tanino et al., 2002; Traves, Culpitt, Russell, Barnes, & 
Donnelly, 2002). Activated neutrophils have the capacity to induce lung tissue damage by 




neutrophil elastase) as well as MMP-8 and -9, which may cause alveolar destruction 
(Ilumets et al., 2008). 
T lymphocytes are another cell type implicated in the inflammatory process 
leading to emphysema (Barnes & Cosio, 2004). The number of CD8-positive T 
lymphocytes is elevated in the airways and lung parenchyma of patients with emphysema 
(Saetta et al., 1999). The degree of airflow obstruction and the extent of the disease are 
also correlated with the number of these inflammatory cells, as reported by numerous 
studies, suggesting that these cells can potentially cause tissue injury in COPD 
(Finkelstein et al., 1995; Majo, Ghezzo, & Cosio, 2001). CD8-positive T cells have been 
implicated to cause damage to alveolar epithelial and endothelial cells in COPD patients 
by releasing multiple proteolytic enzymes such as perforin and granzyme A (Chrysofakis 
et al., 2004; Vernooy et al., 2007). CD4-positive T cells are also increased in the airways 
and parenchyma of COPD patients (Hogg et al., 2004; Retamales et al., 2001). Activated 
and oligoclonal CD4-positive T cells appear exclusively in the lung suggesting that the 
accumulation of these cells is a response to specific antigens present within the lung 
tissue (Sullivan et al., 2005). It has also been demonstrated that CD4-positive T cells 
express the signal transducer and activator of transcription 4 (STAT4), which induces 
differentiation of T cells into Th1 cells producing interferon-γ (Di Stefano et al., 2004). 
The number of CD4-positive T cells expressing interferon-γ positively associates with the 
degree of airflow obstruction in COPD patients (Di Stefano et al., 2004). The recruitment 
and activation of inflammatory cells, macrophages, neutrophils, CD4 and CD8 positive 




In addition to the inflammatory cells, epithelial and vascular endothelial cells are 
also important sources of inflammatory mediators and proteases involved in emphysema 
(Mercer et al., 2004; Taraseviciene-Stewart et al., 2005). When stimulated by cigarette 
smoke, these structural cells release proteases, critical for the development of 
emphysema, and various proinflammatory cytokines such as TNF-α and interleukins 
(Betsuyaku et al., 2008; Mercer et al., 2004; Rusznak et al., 2000). These cytokines 
amplify the recruitment of macrophages, which results in elevated expression of elastases 
and collagenases. Enhanced proteolytic activity within the lung causes the destruction of 
alveolar walls and leads to the pathological pulmonary remodeling (Suki, Lutchen, & 
Ingenito, 2003). Under physiological conditions, epithelial cells are involved in the 
survival of alveoli. They express vascular endothelial growth factor that maintains the 
alveolar cell survival and inhibition of its receptors may culminate in the alveolar 







5.2.  Protease - antiprotease imbalance 
As mentioned above, proteolytic enzymes play a prominent role in the 
development and progression of emphysema. Numerous studies support the protease-
antiprotease imbalance theory, which suggests that excessive activity of proteases or the 
decreased function of pulmonary antiproteases may result in the pathological destruction 
of the lung extracellular matrix, leading to abnormal enlargement of airspaces (Shapiro, 
2003). It has been demonstrated that various proteases including cysteine proteases 
(cathepsins), serine proteases (neutrophil elastase) and matrix metalloproteinases degrade 
the connective tissue of the lung and participate in emphysema formation (D'Armiento et 
al., 1992; Senior et al., 1977; Wang et al., 2000).  
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes 
responsible for the degradation and remodeling of extracellular matrices during 
physiological and pathological events (Lemaitre & D'Armiento, 2006). Recent studies 
demonstrate that MMPs can also cleave non-extracellular matrix molecules such as 
growth factors, cytokines and their receptors (Shiomi et al., 2010). Some MMPs are 
membrane-anchored but most MMPs are secreted as proenzymes that require cleavage of 
the pro-domain for activation (Visse et al., 2003). The molecular structure of MMPs 
generally consists of four functional domains: signal peptide for secretion; propeptide; 
the catalytic domain with a conserved motif binding a zinc ion involved in proteolysis; 
and the C-terminal hemopexin-like domain, which mediates substrate and inhibitor 
interactions (Visse et al., 2003). Pro-MMPs may be activated by other active MMPs, by 
serine proteases such as plasmin, or by reactive oxygen species (Visse et al., 2003). 




MMPs in vivo. In addition, decreased activity of TIMPs can lead to excessive tissue 
breakdown (Shaker et al., 2008). Studies, implicating either animals or human subjects, 
demonstrate that decreased levels of TIMP-1 are associated with the development of 
pulmonary emphysema (Funada, Nishimura, & Yokoyama, 2004; Shaker et al., 2008).  
The role of proteases in the development of emphysema was initially 
demonstrated in patients deficient in α1-antitrypsin, which is a potent inhibitor of 
neutrophil elastase (serine protease) (Eriksson, 1964; Morse, 1978a, 1978b). The 
resulting excessive activity of this elastolytic enzyme was thought to be responsible for 
the destruction of pulmonary elastin, causing early-onset emphysema (Senior et al., 
1977). Moreover, cigarette smoke can contribute to the inhibition of α1-antitrypsin 
expression suggesting that even smokers without α1-antitrypsin deficiency can be 
affected by a protease imbalance (Carp & Janoff, 1978). Neutrophil elastase has 
additional functions that are important in the development of emphysema including 
induction of cytokine activity (IL-8) (Nakamura, Yoshimura, McElvaney, & Crystal, 
1992) and impairment of macrophage ability to clear apoptotic cells (Vandivier et al., 
2002).  Another powerful inhibitor of serine proteases is the secretory leukocyte protease 
inhibitor (SLPI) (Gauthier, Fryksmark, Ohlsson, & Bieth, 1982). Its activity can be 
terminated either by oxidative stress or by active cathepsin B, L and S (Taggart et al., 
2001). In addition, epithelial lining fluid samples from patients with emphysema 
demonstrate the presence of cleaved SLPI and active cathepsin L (Taggart et al., 2001). 





The development of emphysema in mice overexpressing MMP-1 (interstitial 
collagenase) in the lung provides the first evidence for the importance of collagenolytic 
MMPs in the pathogenesis of emphysema (D'Armiento et al., 1992). These mice develop 
severe emphysema due to the degradation of type III collagen, one of the major 
components of the lung extracellular matrix (Shiomi et al., 2003), suggesting that MMP-1 
may play a key role in the human disease. Bronchoalveolar fluids from patients with 
emphysema exhibit elevated levels of MMP-1 compared to healthy subjects (Finlay et al., 
1997), and our laboratory demonstrated that MMP-1 is expressed in type II pneumocytes 
of human emphysematous lungs (Imai et al., 2001).  Importantly, cigarette smoke extract 
induces the expression of MMP-1 in human lung epithelial cells in culture (Mercer et al., 
2004).  MMP-1 upregulation by smoke is dependent on the extracellular regulated kinase 
(ERK), which is activated in human emphysema (Mercer et al., 2004), and is controlled 
by a specific smoke responsive element in the promoter region of MMP-1 (Mercer, 
Wallace, Brinckerhoff, & D'Armiento, 2009).  Together, these studies indicate that 
pulmonary MMP-1 upregulation is a critical event in the development of emphysema in 
smokers. Non-collagenolytic MMPs may also contribute to the disruption of the lung 
extracellular matrix observed in emphysema. Alveolar macrophages of patients with 
emphysema exhibit increased expression of MMP-9, an elastase (Finlay et al., 1997). 
Moreover, MMP-9 expression in alveolar macrophages of smokers is elevated compared 
to non-smokers, suggesting that cigarette smoke induces MMP-9 synthesis (Lim et al., 
2000). It was later demonstrated in our laboratory that overexpression of MMP-9 in the 
macrophages of transgenic mice leads to the formation of emphysema through a loss of 




elastase) in the development of emphysema was first suggested in a study showing that 
mice deficient in this protease were protected against cigarette smoke-induced 
emphysema (Hautamaki et al., 1997). Furthermore, overexpression of IL-13 in MMP-12 
knockout mice did not produce the significant inflammatory and emphysematous changes 
observed in wild-type mice (Lanone et al., 2002). These studies demonstrate that MMP-
12 is important in the development of murine empnhysema.  However, no increase in 
MMP-12 expression or activity has been found in human emphysema (Ohnishi, Takagi, 
Kurokawa, Satomi, & Konttinen, 1998), and therefore the exact contribution of MMP-12 
in the human disease remains controversial. 
Cathepsins are another class of proteases involved in the pathogenesis of 
emphysema and include serine, aspartate and cysteine proteases (Berdowska, 2004). 
Cysteine cathepsins are synthesized as preproenzymes, which are stored in lysosomes 
where they serve their function of protein hydrolysis (Berdowska, 2004). These enzymes 
contribute to distinct physiologic processes, such as antigen presentation in the immune 
system, collagen turnover in bone and cartilage, keratinocytes differentiation, hair follicle 
cycle, reproduction and apoptosis (Honey et al., 2003; Stoch, 2008; Funkelstein et al., 
2008). Excessive activity of these enzymes has been detected in various pathologies, such 
as arthritis, cancer, atherosclerosis, and pulmonary disease (Mohamed, 2006; Lutgens, 
2007). Bronchoalveolar lavage (BAL) fluids obtained from patients with emphysema 
contain increased concentrations of cathepsin L compared to smokers and non-smokers 
without emphysema (Takeyabu et al., 1998). Animal models of emphysema also indicate 
the likely contribution of cathepsins to emphysema development. For example, mice 




emphysematous lungs (Wang et al., 2000). In addition, it has been shown that inhibition 
of cathepsin S decreases IFN – γ -induced inflammation and airspace enlargement (Zheng 
et al., 2005). The role of cathepsin K in collagen degradation has been demonstrated in 
Cathepsin K-deficient mice exhibiting decreased collagenolytic activity and development 
of fibrosis (Buhling et al., 2004). Together, these studies suggest a general role for 





Table 2. Proteolytic enzymes (MMPs, cysteine and serine proteases), their extracellular 
matrix (ECM) substrates and cellular expression. 
 

































Stromelysin-2 (MMP-10)  
 
 




Matrilysin-2 (MMP-26)  
 
 
Stromelysin-3 (MMP-11)  
 











Collagen I, II, III, VII and X; 
gelatin; aggrecan; link protein; 
entactin; tenascin; perlecan 
 
Collagen I, II, III, VII and X; 
gelatin; aggrecan; link protein 
 
 
Collagen I, II, III, IV, IX, X and 
XIV; aggrecan; tenascin; 
osteonectin; perlecan 
 
Gelatin; collagen IV, V, VII, X 
and XI; elastin; aggrecan; link 
protein 
 
Gelatin; collagen III, IV and V; 
aggrecan; elastin; entactin; link 
protein; vitronectin; 




Aggrecan; decorin; gelatin; 
collagen III, IV, IX and X; 
tenascin; link protein; perlecan 
 
Aggrecan; collagen III, IV and V; 
link protein 
 
Aggrecan; gelatin; elastin; 
entactin; collagen IV; tenascin; 
decorin; link protein 
 
































Macrophages; neutrophils; mast 
cells; lymphocytes; NK cells; 
dendritic cells; bronchial 
epithelial cells; alveolar type II 
cells; fibroblasts; smooth muscle 
cells; endothelial cells 
 







Alveolar type II cells; airway 
epithelial cells; macrophages 
 
 
Alveolar type II cells; epithelial 




Macrophages; dendritic cells; 
lymphocytes; fibroblasts; human 
airway smooth muscle cells 
 


















































Collagen II, IV, IX, X, and XI; 
elastin; fibronectin; laminin 
 
 




Collagen I, II, III, IV, IX, and XI; 
















Elastin; gelatin; collagen IV; 
telopeptides of fibrillar collagens; 
proteoglycan 
 
Elastin; gelatin; collagen IV; 




Elastin; gelatin; proteoglycan 
 












Macrophages; airway epithelial 




Neutrophils; mast cells; 
macrophages; epithelial cells; 











smooth muscle cells, endothelial 









References: Shiomi et al., 2010; Foronjy et al., 2001; Atkinson et al., 2003; Wolters et al., 









5.3.  Oxidative stress 
Oxidative stress plays a pivotal role in the pathogenesis of pulmonary 
emphysema. Oxidant/antioxidant imbalance is significantly implicated in tissue 
destruction and apoptosis, both of which play a central role in the development of smoke-
induced emphysema (Imai et al., 2005; Segura-Valdez et al., 2000). Cigarette smoke 
contains high concentrations of reactive oxygen species. It is estimated that each puff of 
cigarette smoke contains 5,000 toxic compounds, 1015 free radicals and potent oxidants 
(Church & Pryor, 1985; Pryor & Stone, 1993). These oxidant molecules damage 
pulmonary epithelial cells by causing direct injury to the cellular membrane and its DNA 
(Faux et al., 2009). Oxidative stress augments inflammation, inactivates inhibitors of 
proteolytic enzymes and causes apoptosis of alveolar cells ultimately leading to the 
formation of emphysema (Rahman et al., 2006; Buttke et al., 1994). Oxidative stress also 
activates the transcription factor nuclear factor-B signaling, which consequently induces 
proinflammatory cytokine transcription (S. R. Yang et al., 2006). 
The absence of equilibrium between oxidants and antioxidants has been shown in 
patients with COPD (Rahman et al., 1996). A profound decrease in antioxidant capacity 
and elevated levels of lipid peroxidation products were demonstrated in the plasma of 
COPD patients and chronic smokers, but not in healthy nonsmokers (Rahman et al., 
1996). Another study shows that exhaled hydrogen peroxide is elevated in the breath 
condensate of patients with COPD and thus provides more evidence for the presence of 
oxidative stress during the disease (Dekhuijzen et al., 1996). These studies highlight the 




There is compelling evidence that antioxidants determine the susceptibility to 
smoke-induced emphysema (Rangasamy et al., 2004). Mice deficient in NRF2 (nuclear 
factor, erythroid-derived 2, like 2) develop profound bronchoalveolar inflammation and 
more extensive smoke-induced emphysema (Rangasamy et al., 2004). NRF2 is a master 
transcription factor, which is involved in the regulation of many detoxification and 
antioxidant genes (Rangasamy et al., 2004). In addition, disruption of this protein causes 
oxidative stress and apoptosis of alveolar septal cells, which include endothelial and type 
II epithelial cells (Rangasamy et al., 2004).  
Research from our laboratory has identified that mice overexpressing copper-zinc 
superoxide dismutase (SOD1) in the lung are protected against smoke and elastase 
induced emphysema, suggesting an important role for this antioxidant in the disease 
process. SOD1, as an antioxidant, defends the lung against the damaging effects of 
cigarette smoke by converting superoxide into hydrogen peroxide (R. F. Foronjy et al., 
2006). This study demonstrated that enhanced expression of superoxide dismutase 
(SOD1) leads to the attenuation of neutrophilic inflammation and oxidative damage in 
smoke-exposed mice. In addition, overexpression of this antioxidant counteracted 
proteolytic cascades involving MMP-12 and MMP-13, leading to the development of 
emphysema (R. F. Foronjy et al., 2006). 
Additional research work provides evidence suggesting that the development of 
smoke-induced emphysema in mice is also dependent on the activity of the extracellular 
superoxide dismutase (SOD3) (Yao et al., 2010). Smoke-exposed mice deficient in SOD3 
develop airspace enlargement and impaired lung function and mice overexpressing SOD3 




suggest that extracellular superoxide dismutase plays a pivotal role in protecting the lungs 
from oxidative stress caused by cigarette smoke (Yao et al., 2010).  
In conclusion, these findings suggest that oxidative stress secondary to cigarette 
smoke operates as a crucial pathological mechanism linking inflammation, excessive 
proteolytic activity, and apoptosis in the emphysematous lung.  Therefore, targeting 
oxidative stress with antioxidants may have beneficial outcome in the treatment of 
smoke-induced emphysema. However, the oxidative mechanisms involved in this 
pathology are very complex and need to be fully elucidated before a successful 





5.4.  Apoptosis 
Destruction of the lung extracellular matrix and alveolar walls results in airspace 
enlargement, which is a prominent characteristic of emphysema. In addition to excessive 
activity of proteases in the lung, the presence of programmed cell death or apoptosis also 
contributes to the development of emphysema (Imai et al., 2005; Segura-Valdez et al., 
2000). There are many factors, which trigger cellular apoptosis, and among them are: loss 
of contact with the extracellular matrix; direct induction by inflammatory cells; and 
severe damages caused by various stresses (Demedts et al., 2006). 
Three different signaling pathways have been involved in the regulation of 
apoptosis (Demedts et al., 2006). All of them result in the activation of various caspases 
and most importantly in the activation of caspase 3, an important protease, which 
excessive activity leads to epithelial apoptosis and the development of emphysematous 
changes (Aoshiba, Yokohori, & Nagai, 2003; Imai et al., 2005). One pathway is activated 
by extracellular signals and is regulated by binding of Fas, a member of tumor necrosis 
factor family, to death receptors positioned on the cell membrane (Demedts et al., 2006). 
This results in the activation of caspase-8 followed by the activation of caspase 3, which 
then initiates the execution of apoptosis by releasing DNAse (Hirata et al., 1998). A 
second pathway is the mitochondrial intrinsic pathway, which implicates the release of 
cytochrome C from mitochondria (Li et al., 1997). This pathway leads to the activation of 
caspase 9 and caspase 3. Ultimately, the endoplasmic reticulum pathway involves the 
activation of caspase 12 in response to stress signals (Rao et al., 2001). These molecular 




apoptosis and proliferation. Disturbance of this equilibrium might contribute to the 
development of emphysema. 
There is a body of evidence revealing the causal relationship between apoptosis 
and pulmonary emphysema. It has been demonstrated that the intratracheal 
administration of the activated caspase 3 leads to alveolar apoptosis and ultimately to the 
development of emphysema in mice (Aoshiba et al., 2003). Furthermore, the 
administration of a broad-spectrum caspase inhibitor prevents septal cell apoptosis and 
the development of emphysema in rats, suggesting that there is a strong link between 
alveolar apoptosis and pulmonary emphysema (Kasahara et al., 2000). 
Another mediator of apoptosis in the pathogenesis of emphysema – besides 
caspase 3 – is ceramide, a lipid mediator (Petrache et al., 2005). It has been shown that 
ceramide triggers apoptosis of alveolar epithelial and endothelial cells, causing airspace 
enlargement in mice. In addition, increased levels of ceramide are found in the lungs of 
patients with emphysema, suggesting an important role for this highly regulated 
sphingolipid second messenger in the pathology of emphysema (Petrache et al., 2005). 
Presence of a higher apoptosis level in human emphysematous lungs has been 
demonstrated in numerous studies (Imai et al., 2005; Segura-Valdez et al., 2000). In our 
laboratory, it has been shown that lung tissue from the patients with emphysema manifest 
elevated numbers of epithelial and endothelial apoptotic cells, together with an increase 
in caspase 3 activation (Imai et al., 2005). Another study reveals a significant increase in 
endothelial cell apoptosis in the lungs of COPD patients, with the less frequent 




In addition to clinical studies, animal models of emphysema also support the 
hypothesis that alveolar cell apoptosis contributes to the development of the disease 
(Kasahara et al., 2000). Blockage of VEGF receptors in a rat model of emphysema leads 
to apoptosis of alveolar septal cells (Kasahara et al., 2000). Mice overexpressing IFN-γ 
manifest emphysematous changes in their lungs and epithelial cell apoptosis. Moreover, 
treatment of these animals with a caspase inhibitor attenuates apoptosis and ameliorates 
IFN-γ-induced emphysema (Zheng et al., 2005).  
In conclusion, these human and animal studies suggest that the amount of 
knowledge on the role of apoptosis in the pathogenesis of emphysema is growing. Yet, 
more studies identifying the precise molecular mechanisms aiding in the prevention and 





5.5.  Aging 
There is evidence that higher prevalence of emphysema positively correlates with 
age (Halbert et al., 2006). Older people have been exposed to harmful gases and particles 
such as cigarette smoking for longer periods. As one ages, the structure and function of 
the lung deteriorate. The aging lung is characterized by marked structural and 
physiological changes (Janssens, Pache, & Nicod, 1999). Physiological pulmonary 
alterations are associated with a decline in elastic recoil and decreased function of 
respiratory muscles. The decline in elastic recoil is suggested to result from a decrease in 
gas exchange surface area accompanied by a loss of elastin, supporting tissue for 
peripheral airways (Janssens et al., 1999). Interestingly, other research suggests that 
morphologic changes of the aging lung include airspace enlargement but not alveolar 
wall destruction, which is a hallmark of emphysema (Verbeken et al., 1992a, 1992b). 
Molecular mechanisms involved in the aging lung include telomere shortening, 
oxidative stress and DNA damage (Lee, Lu, Fahn, & Wei, 1998). A decline in cellular 
division capacity was attributed to the telomere shortening mechanism: telomeres that 
protect the ends of the chromosomes from deterioration get progressively shorter as cells 
divide (Holt, Shay, & Wright, 1996). It has also been demonstrated that increased levels 
of oxidative stress accelerate telomere shortening and, therefore, aging processes 
(Saretzki & Von Zglinicki, 2002). In addition, oxidative stress induces DNA damage, the 
accumulation of which may account for progressive deleterious pulmonary changes 




Animal models with a decreased lifespan have been shown to contribute 
significantly to the understanding of the aging lung phenomenon. Disruption of Klotho in 
mice causes multiple diseases associated with aging, which include arteriosclerosis, 
osteoporosis and pulmonary emphysema (Kuro-o et al., 1997). Klotho protein is involved 
in the regulation of multiple signaling pathways, such as FGF (fibroblast growth factor) 
and IGF (insulin-like growth factor), mediates the activity of multiple ion channels and 
induces resistance to oxidative stress (Kuro-o, 2008). It has been demonstrated that the 
emphysematous phenotype observed in Klotho mice is likely due to the pulmonary 
overexpression of MMP-9 and downregulation of TIMP-1 (Funada et al., 2004). In 
addition, there is a possibility that the observed emphysematous changes are due to the 
excessive damage of oxidative stress, which results from Klotho deficiency (Kuro-o, 
2008).  
Senescence Marker Protein-30 (SMP30) - deficient mice develop airspace 
enlargement and manifest increased susceptibility to harmful stimuli. When exposed to 
cigarette smoke, these mice demonstrate significant parenchymal destruction and 
emphysematous changes (Sato et al., 2006). SMP30 is also involved in the defensive 
mechanism against oxidative stress and its loss is associated with an elevated expression 
of protein carbonyl, which is a marker of oxidative stress that increases with aging (Sato 
et al., 2006). 
Inflammation has been documented in age-associated diseases, which include 
emphysema with increased recruitment of inflammatory cells and elevated circulating 
concentrations of proinflammatory cytokines such as IL-1β, IL-6, IL-8 and TNF-α (Ito & 




that immune response in elderly people is likely being impaired (Ito & Barnes, 2009). In 
addition, an increased number of neutrophils and the excessive production of neutrophil 
elastase in the lower respiratory tract of the healthy but older generation have been 
reported (Meyer, Rosenthal, Soergel, & Peterson, 1998).  
These human and animal studies indicate a strong link between aging and the 
development of emphysema. Aging is a complex process influenced by various intrinsic 
and environmental risk factors, in particular, by oxidative stress and cigarette smoking. 







6. Animal Models of Emphysema 
Animal species such as guinea pigs, dogs, rats and mice have been used to study 
the development of emphysema (Wright, Cosio, & Churg, 2008; Chapman, 2008). There 
are several major experimental approaches to reproduce emphysema in vivo, which 
include inhalation of noxious stimuli (exposure to cigarette smoke), tracheal instillation 
of tissue-degrading enzymes (treatment with elastase) and gene-modifying techniques 
leading to emphysema-like phenotype (Wright et al., 2008). 
 
6.1.  Smoke-induced emphysema  
Animal models exposed to cigarette smoke have provided valuable insights into 
the development of emphysema. The mode of exposure to tobacco smoke may be either 
active, via nose-only exposure systems, or passive via large whole-body chambers 
(Mauderly et al., 1989). Animal models of smoke-induced emphysema manifest 
dilatation of alveolar ducts and exhibit lesions similar to mild centrilobular emphysema 
(Cavarra et al., 2001). Measurements of air space size (morphometric analysis) and 
destructive index analysis should be performed on these animals to evaluate accurately 
the degree of lung damage. It has been shown that guinea pigs exposed to cigarette smoke 
for three months develop emphysema-like airspace enlargement associated with 
increased pulmonary compliance and total lung volumes (Wright & Churg, 1990). 
Interestingly, cessation of smoke exposure in the guinea pig model stabilizes but does not 
reverse emphysematous lung enlargement (Wright & Sun, 1994). 
Rat species produce airspace enlargement with excessive elastin breakdown and 




Abboud, 1998).  Another study involving rats examines the effects of long-term smoking 
on the lungs and demonstrates the development of emphysema and a loss of elastic recoil 
after 6 months of exposure (Huber et al., 1981). 
Significant questions concerning the development of emphysema are 
approachable with mouse models. However, susceptibility of mice to emphysema is 
dependent on the genetic background (Churg, Cosio, & Wright, 2008). After 6 months of 
cigarette smoke exposure, C57BL/6 and A/J mice develop airspace enlargement 
accompanied by a significant infiltration of macrophages (Hautamaki et al., 1997). 
Research in our laboratory shows that CBA/J/J x C57BL/6J mice require one year of 
exposure to smoke in order to develop significant emphysematous changes, with a 17% 
increase in mean linear intercept. Another strain of mice, A/J, appears to be more 
susceptible to cigarette smoke and exhibits a greater loss of lung tissue, with 32% 
increase in mean linear intercept after only 6 months of exposure. Of note, despite this 
striking change in lung morphometry, compliance in the A/J mice did not change (R. F. 
Foronjy et al., 2005). These data suggest that the factors responsible for the development 
of structural emphysema may differ significantly from those that alter the physiologic 
characteristics of the lung. 
 
6.2.  Elastase-generated emphysema  
Tracheal instillation of tissue-degrading enzymes is another experimental 
approach to reproduce emphysema in animals. In 1965 research work conducted by 
Gross et al. demonstrated that instillation of the plant protease, papain, induced 




the hypothesis, for the first time, that emphysema develops as a result of excessive 
activity of proteases that destroy lung extracellular matrix. Intrapulmonary challenge with 
various proteases including porcine pancreatic elastase, papain, and human neutrophil 
elastase generates emphysema in animal models (Johanson & Pierce, 1973; Kaplan, 
Kuhn, & Pierce, 1973; Karlinsky, Goldstein, Catanese, & Snider, 1986).  
The major advantage of the elastase approach is the rapid induction of 
emphysema. Elastase instillation can quickly produce severe emphysema with 
abnormalities of pulmonary function as compared to the slow smoke-induced emphysema 
(Wright et al., 2008). In addition, this technique can be very useful to study the effects 
occurring after proteolytic injury, which is necessary for the understanding of the 
pathology (Wright et al., 2008). However, the major disadvantage of the quick elastase-
generated emphysema is that the detailed mechanism of this process is likely to be 
different from the mechanism of slowly developing smoke-induced emphysema in 
humans. 
 
6.3. Genetically altered animal models of emphysema 
Transgenic and gene targeted mice can be utilized to determine protein function in 
vivo and to dissect the mechanisms leading to the development of emphysema (Shapiro, 
2008). Transgenic models add significantly to the field of emphysema. These animal 
models provide valuable knowledge about the role of inflammatory cytokines and 
proteases contributing to the lung destruction (Table 3). Transgenic mice constitutively 
overexpressing human interstitial collagenase (MMP-1) manifest significant airspace 




collagenases and emphysema (D'Armiento et al., 1992). Mice with lung specific 
overexpression of TNF-α exhibit inflammation and extensive airspace enlargement 
accompanied by bronchiolitis. It has also been noted that the development of emphysema 
in these mice is due to the activation of the elastolytic MMPs, which underscores the 
matrix degrading functions of the MMPs (Fujita et al., 2001). Inducible overexpression of 
interleukin 13 (IL-13), a potent cytokine, in an adult murine lung generates profound 
emphysematous changes with increased pulmonary compliance and marked 
inflammation. Of note, the degradation of pulmonary tissue in these mice is likely due to 
the excessive activity of MMPs and cathepsins suggesting that IL-13 is a potent inducer 
of both MMPs and cathepsins during the development of emphysema (Zheng et al., 
2000). Overexpression of IFN-γ in an adult murine lung leads to extensive emphysema 
accompanied by the infiltration of neutrophils and macrophages. The induction and 
activation of potent cysteine proteases and MMP-12 likely contributes to the alveolar 
destruction in these mice (Wang et al., 2000).  
Another category of gene targeted mice does not develop emphysematous 
changes even if challenged with either long-term cigarette smoke exposure or tracheal 
elastase instillation. Mice lacking MMP-12 (macrophage elastase) not only preserve 
normal lung structure but also fail to generate inflammatory changes even if they are 
exposed to cigarette smoke for 6 months (Hautamaki et al., 1997). Neutrophil elastase-
deficient mice are significantly protected (59%) against emphysema induced by cigarette 
smoke. In addition, these mice exhibit a decreased number of neutrophils and monocytes 
and low macrophage counts, suggesting that the absence of neutrophil elastase prevents 




emphasize the involvement of inflammatory cells and proteases in the pathogenesis of 
emphysema. A number of studies targeted the production and signaling of 
proinflammatory cytokines TNF-α and IL-1β (Churg et al., 2009; Lucey et al., 2002). 
These cytokines have been shown to be implicated in the development of emphysema 
and are consistently elevated in human smokers (Barnes, 2007; Ekberg-Jansson et al., 
2001). Interestingly, after chronic exposure to cigarette smoke IL-1 receptor knockout 
mice are 65% protected against emphysema and mice lacking TNF-α receptors 1 and 2 
are 83% protected (Churg, Zhou, Wang, Wang, & Wright, 2009). Mice deficient in both 
IL-1β receptor 1 and TNF-α receptors 1 and 2 are 81% protected from the development 
of emphysema induced by elastase instillation (Lucey, Keane, Kuang, Snider, & 
Goldstein, 2002). These observations further support the significant role of inflammation 
in emphysema formation. 
Transgenic mouse models may be achieved by overexpressing certain proteins 
and knockout models can be generated through targeted mutagenesis. These animals can 
develop emphysema spontaneously with age or after being challenged with cigarette 
smoke. Surfactant protein D (SP-D)-deficient mice develop emphysema at 3 weeks of 
age. Emphysema in these mice is associated with pulmonary infiltration by cholesterol-
loaded macrophages, which are known as foam cells. These lipid-loaded macrophages 
induce oxidative stress with consequent activation of NF-kappa-B signaling and 
increased MMP expression (M. Yoshida, Korfhagen, & Whitsett, 2001). Mice with lung 
targeted VEGF inactivation develop an emphysema-like phenotype with alveolar and 
bronchial cell apoptosis and loss of lung elastic recoil but without an obvious 




these studies demonstrate an important role for SP-D and VEGF in emphysema in mice 
and suggest that their dysregulation could be important in the human disease.  
These murine models provide a valuable insight into the cellular and molecular 
mechanisms that lead to the development of emphysema and explore the role of factors 
that mediate normal alveolar development. Together they pose the question of whether or 





















Table 3. Rodent models of emphysema. Adapted from Taraseviciene-Stewart L., 2008. 
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knockout 
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7. Molecular mechanisms of emphysema  
Numerous studies examine the molecular mechanisms of inflammation and 
protease production leading to alveolar destruction. These signaling pathways can be 
activated by exposure to cigarette smoke or by a variety of cytokines and growth factors. 
The most characterized pathways implicated in the pathogenesis of emphysema are 
MAPK, mTOR, Stat3, VEGF, TLR, Wnt, and NF-kB signaling (Mercer et al., 2006; Qu 
et al., 2009; Yoshida et al., 2010; Kasahara et al., 2001; Kneidinger et al., 2010).  
Mitogen activated protein kinase (MAPK) signaling has been demonstrated not 
only in animal models of emphysema but also in the lungs of patients with the disease 
(Mercer et al., 2004). The best described MAPK signaling pathway involves extracellular 
regulated kinase (ERK), which is involved in many cellular processes such as cell 
proliferation, differentiation, motility, and death (Mercer & D'Armiento, 2006). Exposure 
to cigarette smoke or binding of growth factors to a receptor tyrosine kinase leads to the 
dimerization and autophosphorylation of the receptor, which ultimately activates 
MEK1/2 and ERK1/2 (Mercer & D'Armiento, 2006). There is a growing body of 
evidence, which suggests that activation of ERK leads to the upregulation of proteolytic 
enzymes implicated in the destruction of pulmonary tissue (Mercer et al., 2004).  
It has been identified by our laboratory that ERK is activated in the lungs of 
patients with emphysema and that the induction of MMP-1, a potent protease responsible 
for the collagen degradation, by cigarette smoke in small airway epithelial cells is ERK-
dependent (Mercer et al., 2004). Other research demonstrates that secreted frizzled-
related protein 1 (SFRP1), which exhibits elevated levels in the lungs of emphysema 




al., 2010). These findings suggest that MAPK signaling plays an important role in the 
deregulation of the proteolytic balance in the lung extracellular matrix. 
The mammalian target of rapamycin (mTOR) signaling also plays a role in the 
pathogenesis of emphysema. There is evidence demonstrating inhibition of mTOR 
signaling during the development of murine emphysema, which suggests that mTOR 
activity contributes to the maintenance of lung homeostasis (T. Yoshida et al., 2010). 
Overexpression in mouse lungs of RTP801, a stress-related protein triggered by adverse 
environmental conditions, downregulates mTOR signaling, which ultimately results in 
the recruitment of inflammatory cells, oxidative stress and apoptosis (T. Yoshida et al., 
2010). Moreover, it has been demonstrated that administration of rapamycin, an inhibitor 
of mTOR signaling, leads to an increased pulmonary inflammation and induces alveolar 
cell apoptosis in mice (T. Yoshida et al., 2010). 
Signal transducer and activator of transcription-3 (Stat3) signaling has been 
implicated in the pathogenesis of emphysema (Qu et al., 2009). Its been demonstrated 
that mice overexpressing MMP-12 develop pulmonary inflammation and spontaneous 
emphysema through the activation of Stat3 signaling (Qu et al., 2009). Increased MMP-
12 activity leads to the inflammatory cell infiltration and increased concentrations of IL-
6, which is a potent proinflammatory cytokine (Qu, Du, Wang, & Yan, 2009). IL-6 
treatment augments Stat3 phosphorylation in alveolar type II epithelial cells in vivo (L. 
Yang et al., 2004). In addition to these observations, there is evidence that Stat3 plays a 
key role in MMP-1 production. These findings demonstrated that the inhibition of Stat3 
signaling decreases the secretion of MMP-1 by pulmonary fibroblasts (O'Kane et al., 




the increased MMP-1 and MMP-12 activity, which might ultimately result in the 
development of emphysema.   
Vascular endothelial growth factor (VEGF) is a survival factor for endothelial 
cells (Neufeld, Cohen, Gengrinovitch, & Poltorak, 1999; Senger et al., 1983). The 
activity of VEGF is mediated through VEGFR-1, VEGFR-2, and VEGFR-3 (Giles, 
2001). VEGFR-1 is expressed on endothelial cells and mediates cell motility (Giles, 
2001). The proliferative and mitogenic activities of VEGF are regulated by VEGFR-2. 
VEGFR-3 is believed to be involved in lymphoangiogenesis (Giles, 2001). Upon ligand 
binding, receptor activates a range of signaling molecules, such as phosphatidylinositol 3-
kinase (PI3K), growth factor receptor-bound protein 2 (Grb2), and SH2 domain-
containing phosphatases (SHP-1 and SHP-2). Activation of VEGF signaling leads to 
endothelial cell proliferation, vasopermeability, and angiogenesis (Giles, 2001). VEGF 
signaling plays a key role in the maintenance of endothelial cells and alveolar structures 
and under normal conditions VEGF is highly expressed in the lungs (Kasahara et al., 
2001). The reduction of VEGF levels in the lungs may result in parenchymal loss, 
alveolar wall destruction and ultimately emphysema. In addition, it has been 
demonstrated that patients with emphysema have decreased expression of VEGF and 
endothelial cell apoptosis as compared with normal patients (Kasahara et al., 2001). 
Murine models also underline the importance of VEGF signaling in emphysema. 
Inhibition of VEGF signaling through VEGFR-2 blockade in rats leads to the destruction 
of pulmonary parenchyma and enlargement of alveoli (Kasahara et al., 2000). This 
emphysema phenotype is associated with elevated caspase-3 activity, which leads to 




rats with caspase inhibitor prevents the development of emphysema, suggesting a 
contributory role of apoptosis in this disease (Kasahara et al., 2000). Furthermore, mice 
with decreased expression of pulmonary VEGF (86%) also exhibit alveolar wall 
destruction, increased lung compliance (loss of elastic recoil), and augmented expression 
of caspase-3 (Tang et al., 2004). Therefore, these observations imply that decreased 
VEGF signaling causes endothelial and epithelial cell apoptosis, which ultimately may 
result in the development of emphysema. 
Toll-like receptor (TLR) signaling has a distinct role in the development of 
emphysema. This signaling pathway is activated in response to the products of tissue 
damage, viruses, and bacteria (Means et al., 2000). TLRs are expressed not only in 
airway and alveolar type II epithelial cells but also in alveolar macrophages and 
neutrophils (Armstrong et al., 2004; Fernandez, Jose, Avdiushko, Kaplan, & Cohen, 
2004). This extensive expression of TLRs within the lung suggests that TLR activation is 
likely to contribute to the development of emphysema (Armstrong et al., 2004; Fernandez 
et al., 2004). In addition, ablation of IL-1R1 and MyD88, downstream regulators of TLR 
signaling, in mice prevents lung inflammation and pathology (Couillin et al., 2009). In 
contrast to the findings mentioned above, TLR-4 deficient mice develop emphysematous 
changes associated with oxidative stress and elastin breakdown (X. Zhang, Shan, Jiang, 
Cohn, & Lee, 2006). Of note, these mice do not exhibit inflammation, which is a 
hallmark of emphysema, suggesting that the development of the disease in this knockout 
model is atypical.   
Wnt signaling pathway is implicated in the destruction of pulmonary tissue and 




into three distinct pathways (Königshoff et al., 2010). First, the best-characterized WNT 
signaling pathway is the "canonical" β-catenin–dependent WNT pathway. In the absence 
of WNT ligands, β-catenin is attached to the scaffold proteins Axin and adenomatosis 
polyposis coli. It is constitutively phosphorylated via interaction with casein kinase I and 
glycogen synthase kinase (GSK)-3β and subsequently ubiquitinated. Second, the 
WNT/Ca2+ pathway signals via calmodulin kinase II and protein kinase C. Third, the 
WNT/JNK pathway is activated through small GTPases (Königshoff et al., 2010). It has 
been demonstrated that Wnt signaling is reduced in the lungs of patients with COPD and 
during emphysema development in mice (Kneidinger et al., 2010). Patients with COPD 
reveal decreased expression of the downstream regulators of Wnt signaling, such as β-
catenin and Axin1 (Kneidinger et al., 2010). In addition, a recent study from our 
laboratory shows that an inhibitor of Wnt signaling, Secreted frizzled-related protein 1 
(SFRP1), is upregulated in the lungs of patients with emphysema (R. Foronjy et al., 
2010). Experimental mouse models of emphysema also confirm the involvement of this 
signaling pathway in this lung pathology. Elastase-treated and smoke-exposed mice 
exhibit decreased pulmonary expression of the main components of Wnt signaling. 
Moreover, activation of Wnt signaling by lithium chloride in the murine models of 
emphysema leads to the attenuation of airspace enlargement and improved lung 
physiology, which indicates a crucial role for Wnt signaling in emphysema (Kneidinger 
et al., 2010).  
Nuclear factor-kappaB (NF-kappaB) signaling regulates a number of 
proinflammatory and apoptotic genes and thereby may control or contribute to the 




Firestein, 2001). NF-kappaB proteins are normally restricted to the cytoplasm by a set of 
inhibitory proteins, but following receptor-mediated activation of IkappaB kinases, the 
inhibitors are degraded, thereby allowing nuclear import of the transcription factors that 
regulate multiple inflammatory cytokines and mediators (Wong et al., 2010). A 
significant increase in NF-kappaB expression is observed in patients with COPD 
compared to normal subjects suggesting an important role for this signaling in the disease 
(Brown, Elborn, Bradley, & Ennis, 2009). In addition, a recent work demonstrates 
activation of NF-kappaB signaling in the experimental mouse model of emphysema (T. 
Yoshida et al., 2010). These findings show that overexpression of a stress-related protein, 
RTP801, in mouse lungs activates NF-kappaB signaling, which may potentially lead to 
smoke-induced inflammation, pulmonary injury and emphysema. Moreover, RTP801-
deficient mice protected against emphysematous alveolar destruction are greatly 
defective in NF-kappaB activation (T. Yoshida et al., 2010). These potent results 
emphasize the role of NF-kappaB signaling in inflammation and oxidative stress, which 





8.  Emphysema, Diet, and Atherosclerosis 
8.1. Association between atherosclerosis and emphysema (clinical studies)  
The incidence of chronic obstructive pulmonary disease (COPD) in patients with 
cardiovascular diseases (CVD) is undervalued due to limited knowledge about the 
association between COPD and atherosclerosis. The development of COPD in patients 
with atherosclerosis considerably reduces CVD survival rates (Leavitt et al., 2006). In 
addition, cardiovascular morbidity and mortality rates are markedly increased in COPD 
patients (Sidney et al., 2005). A significant correlation between the severity of COPD and 
the cardiovascular morbidity and mortality has been documented (Curkendall et al., 
2006). Another group of investigators report that smokers with airflow limitation exhibit 
severe atherosclerosis compared to smokers without airflow limitation, emphasizing the 
fact that reduced lung function affects the development of atherosclerosis (Iwamoto et al., 
2009). 
The co-morbidity of atherosclerosis and COPD is likely associated with common 
risk factors, such as tobacco smoking. Smoking is an established risk factor for both 
atherosclerosis and COPD (Barnoya & Glantz, 2005; Viegi et al., 2007). Recent research 
work suggests that the mechanism linking atherosclerosis and COPD can be explained by 
persistent systemic inflammation originating from a local infiltration of immune cells 
either to the vessel wall or to the airway (Sin & Man, 2003). Increased levels of C-
reactive protein (CRP) are a marker for systemic inflammation in the patients with COPD 
and atherosclerosis. The levels of CRP are positively correlated with cardiovascular risk 









8.2. Animal models of atherosclerosis 
There are multiple risk factors associated with the development of atherosclerosis, 
however, a common risk factor contributing to the complex and accelerated vascular 
disease in man and animals is elevated plasma cholesterol levels or hypercholesterolemia 
(Libby, 2002). Even though there is no animal model that would be able to entirely 
reproduce human-like pathology, cholesterol feeding and genetic manipulations of 
animals can provide valuable insights into the disease pathology (Daugherty, 2002). It 
has been demonstrated that genetically altered mice and rabbits are useful tools for 
studying the development of atherosclerosis (Daugherty, 2002; J. C. Russell & Proctor, 
2006). Interestingly, in our studies these animals proved to be useful in research related to 
the pathogenesis of emphysema. 
 
8.2.1. Mouse models of atherosclerosis  
Mouse models are widely used to investigate the cellular and molecular 
mechanisms leading to the development of atherosclerosis (Daugherty, 2002). One of the 
reasons for such popularity is that considerable numbers of mice can be easily generated 
due to their short time to sexual maturity and the litter size, which ranges from six to ten 
pups. In addition, they are commonly used for genetic manipulations and are easy to 
handle and maintain. Of note, normal mice either on a chow diet or on a high-cholesterol 
diet are resistant to the development of severe hypercholesterolemia and atherosclerosis 
unless they are genetically modified (Breslow, 1996). Under normal conditions mice 
exhibit increased levels of anti-atherogenic HDL and decreased levels of atherogenic 




fundamental advancement in the atherosclerosis field (Breslow, 1996). The most widely 
used mouse models are the Apolipoprotein E knockout (Apoe-/-) and the Low Density 
Lipoprotein Receptor knockout (Ldlr-/-) mice (Daugherty, 2002). 
Apolipoprotein E (ApoE) is a protein located on the surface of cholesterol-rich 
plasma lipoproteins and functions as a ligand for the receptors mediating hepatic 
clearance of the lipoproteins from the circulation (Ishibashi, Herz, Maeda, Goldstein, & 
Brown, 1994; Mahley, 1988). Most ApoE is generated in the liver, however, numerous 
peripheral tissues are also capable of synthesizing ApoE (Driscoll & Getz, 1984; 
Williams, Dawson, Newman, & Rudel, 1985). The role of ApoE in cholesterol 
homeostasis is clearly demonstrated in Apoe-/- mice. These mice develop exaggerated 
atherosclerosis as a consequence of their severe hypercholesterolemia (Plump et al., 
1992; S. H. Zhang, Reddick, Piedrahita, & Maeda, 1992). Apoe-/- mice have five times 
higher total plasma cholesterol levels compared to that of normal mice even when 
maintained on a chow diet (434 mg/dL versus 86 mg/dL, respectively) (S. H. Zhang et 
al., 1992). When fed a high-cholesterol diet (Western-type diet), Apoe-/- mice increase 
their plasma cholesterol levels even further (ranging from 1085 to 4402 mg/dL). Whereas 
normal mice fed the Western-type diet do not show significantly higher levels compared 
to their counterparts fed chow (from 154 to 301 mg/dL versus 86 mg/dL) (Nakashima, 
Plump, Raines, Breslow, & Ross, 1994). This substantial elevation in plasma cholesterol 
levels in Apoe-/- mice is primarily due to high levels of VLDL and, to a lesser degree, 
LDL-sized particles (Plump & Breslow, 1995). This abnormal lipoprotein profile results 
from a failure to clear lipoproteins from circulation in absence of ApoE (Plump & 




LDL receptor deficiency in humans leads to a massive elevation in circulating 
LDL and pronounced hypercholesterolemia (Goldstein & Brown, 1974). In contrast, Ldlr-
/- mice develop only a modest hypercholesterolemia when maintained on a chow diet 
compared to normal control mice (100 mg/dL vs 239 mg/dL respectively) (Ishibashi et 
al., 1993). Of note, these mice are very sensitive to dietary modifications and when fed a 
high-cholesterol diet they exhibit considerably higher cholesterol levels (1000 mg/dL). It 
has also been demonstrated that Ldlr-/- mice show a significant increase in LDL fraction 
and only a small elevation of VLDL particles (Ishibashi et al., 1993; Ishibashi, Goldstein, 
Brown, Herz, & Burns, 1994). 
HDL scavenger receptor Class B Type 1 (SR-BI) regulates cellular uptake of 
cholesterol and other lipids from HDL particles and promotes efflux of unesterified 
cholesterol from cells to HDL (S. Zhang et al., 2005). Mice that are deficient in SR-BI 
are particularly sensitive to a high-cholesterol diet and rapidly develop high cholesterol 
levels and striking atherosclerosis (S. Zhang et al., 2005). Mice that are deficient in both 
SR-BI and ApoE and maintained on a low fat chow diet exhibit marked 
hypercholesterolemia (average of 1000 mg/dL) and extensive atherosclerosis suggesting 










8.2.2. Rabbit models of atherosclerosis  
Rabbit is a valuable model to study the pathology of atherosclerosis. The rabbit 
rapidly develops severe hypercholesterolemia, which results in premature atherosclerosis 
in response to high-cholesterol feeding (Bocan et al., 1993). The typical plasma 
cholesterol levels in New Zealand White rabbits (NZW) are naturally low, but get 
significantly higher when rabbits fed the cholesterol-enriched diets (78 vs 515 mg/dl). 
(Daley, Herderick, Cornhill, & Rogers, 1994) 
Administration of high-cholesterol diet results in a marked elevation in the 
production of highly atherogenic VLDL particles by the liver and intestine (MacKinnon, 
Savage, Gibson, & Barter, 1985; Thompson & Zilversmit, 1983). Subsequent clearance 
of the VLDL by the liver is decreased due to a downregulation of lipoprotein receptors 
(Kovanen, Brown, Basu, Bilheimer, & Goldstein, 1981). In addition, it has been 
demonstrated that cholesterol-fed rabbits exhibit accumulation of both VLDL and 
chylomicron remnants due to the low activity of LDL receptor (Hussain, Innerarity, 
Brecht, & Mahley, 1995).   
When maintained on a high-cholesterol diet, rabbits develop 
hypercholesterolemia and extensive atherosclerosis (Bocan et al., 1993). It has been 
demonstrated that the administration of a normal chow for 9 months to the rabbits is not 
capable of reversing diet-induced atherosclerosis (Adams & Morgan, 1977). However, 
another group of researchers show that injection of HDL-C and VHDL-C can attenuate 
the pathology highlighting the role for HDL particles in the prevention and treatment of 




There are several strains of hyperlipidemic rabbits that provide valuable insight 
into human disease pathology. The Watanabe heritable hyperlipidemic (WHHL) rabbit is 
an excellent model for understanding human familial hypercholesterolemia (Goldstein, 
Kita, & Brown, 1983; Watanabe, 1980). A hereditary defect in the LDL receptor causes 
pathological accumulation of plasma LDLs and increased cholesterol levels (400 mg/dL), 
which results in development of atherosclerosis (Goldstein et al., 1983). The St. Thomas 
Hospital strain of hyperlipidemic rabbits has increased levels of VLDL, IDL, and LDL 
due to overproduction of these lipoproteins, and therefore this rabbit is a good model for 
familial combined hyperlipidemia (Nordestgaard, Tybjaerg-Hansen, & Lewis, 1992). 
There are also rabbits resistant to cholesterol supplementation that do not rapidly develop 
atherosclerosis. When they are fed a high-cholesterol diet, the levels of plasma 





8.3. Hunger disease and emphysema  
Many studies have suggested a link between malnutrition, starvation and 
emphysema. Malnourished patients with anorexia nervosa have been shown to possess 
reduced diffusing capacity and enlarged airspaces (Coxson et al., 2004). Irreversible 
dilation of the airways has also been noted in a patient with severe anorexia nervosa 
suggesting that there is a possible effect of food deprivation on the development of 
pulmonary pathology (V. J. Cook, Coxson, Mason, & Bai, 2001).  
Numerous studies involving animals suggest that caloric restriction may result in 
the loss of alveoli and lung cells and that refeeding restores normal pulmonary structure 
(D. Massaro et al., 2004; G. D. Massaro, Radaeva, Clerch, & Massaro, 2002). 
Researchers believe that alveolar loss caused by starvation occurs in a regulated manner. 
Calorie restriction in mice aggravates the pulmonary condition up to three days and then 
the effect of starvation on the lung disappears even if the restriction is prolonged (D. 
Massaro et al., 2004). In addition, refeeding of mice with calorie-restricted intake causes 
spontaneous regeneration of alveoli and restoration of pulmonary tissue (G. D. Massaro 
et al., 2002). In contrast, animal models of smoke-induced and elastase-generated 
emphysema manifest the irreversible destruction of alveoli and reduced elastic recoil 
even after the action of the initiators of the disease is discontinued.  
Other animal models of starvation have been developed to confirm the effect of 
caloric restriction on emphysema (Sahebjami et al., 1981; Karlinsky et al., 1986). Food 
restriction causes emphysematous changes in rats and hamsters (Sahebjami et al., 1981; 
Karlinsky et al., 1986). Hamsters produce airspace enlargement accompanied by the 




manifest diminished elastic recoil implying that there is a difference between the 
physiology of smoke-induced and nutritional emphysema (Karlinsky, Goldstein, 
Ojserkis, & Snider, 1986). As noted above, food-restricted rats also develop emphysema. 
Interestingly, the severity of the disease declines in food-restricted rats depleted of 
protein as well (Kerr et al., 1985). These studies highlight the role of starvation in 
emphysema and provide valuable knowledge helping us to understand the numerous 
mechanisms that may contribute to the development or prevention of emphysema. These 
observations also demonstrate that there are many more phenotypes that need to be 





9. Significance of the present study 
 
The goal of the present study is to better understand the molecular mechanisms 
leading to emphysema formation secondary to cigarette smoke and hypercholesterolemia.  
Cigarette smoking is a major risk factor for both chronic obstructive pulmonary disease 
(COPD) and cardiovascular diseases (CVD) (Barnoya & Glantz, 2005; Viegi et al., 
2007). Hypercholesterolemia is a well-established risk factor for the development of 
atherosclerosis (Libby, 2002).   
Cigarette smoke exposure induces pulmonary inflammation and causes oxidative 
stress, apoptosis, and an imbalance between proteolytic enzymes and their inhibitors 
(Sharafkhaneh, Hanania, & Kim, 2008). Excessive activity of proteases in the lungs 
results in the disruption of the extracellular matrix, contributing to the development of 
emphysema (Foronjy, 2001; Shapiro, 1999). However, the precise molecular mechanisms 
responsible for smoke-induced emphysema are still poorly understood. Our laboratory 
has demonstrated that matrix metalloproteinase-1 (MMP-1) plays a key role in this 
pathology.  MMP-1 is expressed in human emphysema and, in transgenic mice it causes 
emphysema through cleavage of type III collagen (Shiomi, 2003; Imai, 2001).  
Importantly, cigarette smoke induces MMP-1 in human epithelial cells (Mercer, 2004).  
However, rodents do not express a true homologue for MMP-1, and therefore the use of 
other models is necessary to further study the role of this protease in smoke-induced 
emphysema (Henriet, Rousseau, & Eeckhout, 1992; Schorpp et al., 1995). In chapters 
two and four of this thesis, we examine the histologic and molecular effects of smoke 
exposure on the lungs of guinea pigs and rabbits, two species that express a homologue 




Recent publications in peer-reviewed journals have suggested the existence of a 
link between COPD and CVD (Sidney et al., 2005; Leavitt et al., 2006).  It has been 
demonstrated that cardiovascular morbidity and mortality rates are markedly increased in 
patients with COPD (Sidney et al., 2005). Moreover, the development of COPD in 
patients with atherosclerosis considerably reduces CVD survival rates (Leavitt et al., 
2006). The mechanism linking atherosclerosis and emphysema could be attributed to a 
persistent systemic inflammation originating from a local infiltration of immune cells, 
either to the vessel wall or to the airway (Sin & Man, 2003).  
In the present study we investigate the possible impact of hypercholesterolemia, a 
common feature of atherosclerosis, on the enlargement of airspaces and the destruction of 
alveolar walls. With 12 million patients currently diagnosed with COPD in the United 
States, it is essential to study the molecular mechanisms potentially linking emphysema 
formation and atherosclerosis (Krishnan, 2010). In chapters three and four of this thesis, 
we identify the role of hypercholesterolemia in pulmonary inflammation, proteolytic 
responses, and in the development of emphysema using Apoe-/- and Ldlr-/- mice, and 
rabbits.  
The animal models characterized in our study will contribute to our understanding 
of the signaling pathways by which hypercholesterolemia and cigarette smoke induce 
pulmonary disease. In the future, this research may facilitate the development of new and 


























































































Smokers with airflow obstruction have an increased risk of atherosclerosis, but the 
relationship between the pathogenesis of these diseases is not well understood. To 
determine if hypercholesterolemia alters lung inflammation and emphysema formation, 
we examined the lung phenotype of two hypercholesterolemic murine models of 
atherosclerosis at baseline and on a high-fat diet and explored the mechanism of lung 
injury. Airspace enlargement developed in the lungs of Apoe-/- mice exposed to a 
Western-type diet for 10 weeks. An elevated number of macrophages and lymphocytes 
accompanied by an increase in matrix metalloproteinase-9 (MMP-9) and matrix 
metalloproteinase-12 (MMP-12) expression was observed in the lungs of Apoe-/- mice on 
a Western-type diet. In contrast, Ldlr-/- mice exposed to a Western-type diet for 10 weeks 
did not exhibit lung destruction or inflammatory changes. Most importantly, we revealed 
augmented expression of the downstream targets in the toll-like receptor (TLR) pathway, 
interleukin-1 receptor-associated kinase 1 (IRAK1) and granulocyte colony-stimulating 
factor (G-CSF), in the lungs of Apoe-/- mice. In addition, we demonstrated overexpression 
of MMP-9 in the Apoe-/- macrophages treated with TLR4 ligand, suggesting that 
emphysema in these mice is a result of the activation of the TLR pathway secondary to 
hyperlipidemia and abnormal cholesterol efflux. Our findings indicate that 
hyperlipidemia and abnormal cholesterol efflux lead to increased systemic inflammation 





Emphysema is a chronic obstructive pulmonary disease characterized by the 
abnormal destruction of alveolar walls accompanied by the enlargement of airspaces 
(Sharafkhaneh et al., 2008). Today more than twelve million people in the United States 
are diagnosed with this condition (Krishnan, 2010). The incidence of emphysema in 
cigarette smokers is much higher than in non-smokers and the association between the 
progression of the disease and the degree of cigarette smoking has been documented by 
several studies (Vestbo et al., 2006; Higgins, 1991). Cigarette smoke exposure causes 
increased inflammation (Grumelli et al., 2004), protease/antiprotease imbalance (Shapiro, 
1995), apoptosis (Tuder et al., 2003) and oxidative stress (Rahman et al., 1996). These 
processes are believed to contribute to the alveolar destruction. It has also been shown 
that smokers face an increased risk for numerous diseases, including atherosclerosis. 
Cigarette smoke raises the levels of oxidized low-density lipoprotein (LDL) cholesterol 
and damages vessel endothelium leading to the development of atherosclerosis (Stokes, 
1990). Of note, smokers with airflow limitation have more prominent atherosclerosis than 
smokers with normal lung function, suggesting a link between atherosclerosis and 
obstructive lung disease (Iwamoto et al., 2009).  
One of the major hallmarks of emphysema and atherosclerosis is inflammation 
originating from the infiltration of macrophages and lymphocytes into the airway and 
vessel wall, respectively. Atherosclerotic lesions reveal increased numbers of lipid-laden 
macrophages (Hansson, 2005). Likewise, smokers with airflow limitations exhibit an 
increase in the number of macrophages and T-lymphocytes in the lung (Wouters, 2005). 




progression of emphysema (Larsson, 2007). Animal models of atherosclerosis and 
emphysema demonstrate similar inflammatory profiles (Stoll et al., 2006; Taraseviciene-
Stewart et al., 2008). Therefore, we examined the lungs of two murine models of 
atherosclerosis in order to assess the potential consequences of hyperlipidemia on lung 
structure. 
The most widely used murine models for atherosclerosis are Apoe-/- mice and 
Ldlr-/- mice, which both develop hypercholesterolemia (Veniant et al., 2001; Knowles et 
al., 2000). Under normal conditions, ApoE accepts cholesterol from cells and transports it 
back to the liver where it can be excreted. The loss of ApoE and the LDL receptor result 
in hypercholesterolemic states due to the impaired lipoprotein production and metabolism 
(Veniant et al., 2001; Knowles et al., 2000). One of the critical roles of ApoE is to 
promote cholesterol efflux from macrophages (Basu et al., 1981; Mazzone et al., 1994). 
Deficiency of endogenous ApoE expression leads to the deleterious effects of 
cholesterol-overloaded macrophages, which are also known as foam cells (Reddick et al., 
1994). Accumulation of oxidized LDL in macrophages of the plaque has been 
demonstrated to stimulate the secretion of various cytokines and proteases, which leads to 
the degradation of the components of the extracellular matrix (Shaw, 2004).  The goal of 
this study was to examine the lung phenotype in Apoe-/- and LDLr-/- to determine if the 
hypercholesterolemia and abnormal cholesterol efflux impacted on the extracellular 





Materials and Methods 
Animal experiments 
Two murine models of atherosclerosis were used to study the effect of 
hypercholesterolemia on the lung structure. The first group included 8-week-old female 
Apoe-/- mice (n=6) subjected to a Western diet for 10 weeks, compared to Apoe-/- mice on 
a chow diet (n=6) and Apoe+/+ controls (n=6). In the second group of animals, the Ldlr-/- 
model of atherosclerosis was used to observe the effect of the diet on the lungs.  Ldlr-/- 
female mice were exposed to a Western diet (n=6) or chow (n=6) for 10 weeks. Female 
mice were selected due to their increased susceptibility to the atherosclerotic plaque 
formation. Mice were fed an atherogenic high-fat Western-type diet (20% protein, 50% 
carbohydrate, 21% fat, 0.21% cholesterol; Research Diets, NJ, D12079B). All mice were 
on a C57BL6/J background obtained from Jackson Laboratories. Animals were housed at 
Columbia University Medical Center according to animal welfare guidelines. Food and 
drinking water were provided ad libitum. All animal studies were approved by the 
Columbia University Institutional Animal Care and Use Committee. 
 
Cell Culture 
Peritoneal macrophages were obtained from Apoe-/- and Apoe+/+ mice injected 
intraperitoneally with thioglycollate. The macrophages were cultured in DMEM 
containing 5% FBS (fetal bovine serum) for 24 hours and subsequently treated with 
various toll-like receptor (TLR) ligands. TLR2 [peptidoglycan (PGN), 2µg/ml], TLR3 




component of lipopolysaccharide, 100ng/ml] ligands were used for the experiment. 
Macrophages were also treated with TLR4 ligand and oxidized LDL (100µg/ml).  
 
Histology and immunohistochemistry 
After exposure to the Western or chow diet, mice were sacrificed by carbon dioxide 
inhalation. The trachea was cannulated with a 16g argon catheter secured with a silk 
suture. The lungs were lavaged first with PBS (1ml), to collect bronchoalveolar lavage 
(BAL) fluid, then infused with 10% formalin for 24 hours. Tissues were embedded in 
paraffin and sectioned (6 µm). Sections were stained with hematoxylin and eosin (H&E) 
for histological analysis and quantification of macrophages. Morphometric analysis of the 
H&E stained lungs of 6 mice in each group was performed as previously described 
(Foronjy et al., 2006). Morphometric assessment was conducted to determine the average 
distance between alveolar walls (mean linear intercept), the fractional volume of 
parenchyma tissue per lung, and the alveolar surface area per unit volume. Ten 
histological fields (400X magnification) were analyzed from at least two separate 
sections from each mouse (n=6 in each group) to calculate morphometric parameters.  
 
Western Blotting 
Freshly dissected lungs of Apoe-/- and Ldlr-/- mice (10 mg) were homogenized in 1ml of 
protein lysis buffer (PBS containing Triton X-100 0.1%), and centrifuged (14000g for 10 
minutes). Fifty µg of the lung lysates of each group were subjected to Western Blot 








Zymography was performed to detect proteases having gelatinolytic activity, matrix 
metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) as previously 
reported (Heussen et al., 1980). Ten mg of gelatin (Sigma-Aldrich) were dissolved in 10 
ml of a SDS-polyacrylamide gel.  After loading and migration of the protein samples, the 
gel was washed three times for 20 minutes in Triton X-100 2.5%, to remove the SDS.  
The gel was then placed in 20 ml of a buffer optimal for MMP activity (Tris-HCl 50 mM; 
Triton X-100 1% vol/vol; CaCl2 5 mM; ZnCl2 1 uM; Sodium azide 0.05 % w/v; pH7.4).  
During the overnight incubation at 37C, gelatinolytic enzymes present in the gel digested 
the co-polymerized substrate. After staining with Coomassie blue, the gel appeared blue 
except where the substrate was digested, forming clear bands. This technique is very 
sensitive for the detection of MMP-9 and MMP-2, two highly active gelatinases. 
 
Quantitative RT-PCR 
Total RNA was extracted from two specimens of lung tissue 0.3cm3 in size with the use 
of a RNeasy kit (Qiagen). TaqMan gene expression assays were performed to assess 
gene-transcript levels with the use of an ABI Prism® 7900HT Sequence Detection 
System (Applera Corporation, Foster City, CA). Primer and probe sets were purchased 
from ABI and included the following: MMP-9 (Mm00442991_m1) and matrix 




dehydrogenase (GAPDH) was used as the housekeeping gene. Quantitative real-time 
polymerase chain reaction (qRT-PCR) analysis was performed on lung tissue from four 
animals in each group. To calculate the relative quantity (RQ) of MMP-9 and MMP-12, 
we used the 2 -ΔΔCT method implemented in the software. The data are shown as the fold 
change in gene expression normalized to the endogenous reference gene GAPDH and 
relative to the controls. 
 
Statistical analysis 
Data are shown as mean ±SD. Unpaired two-tailed Student’s t-test analysis was 





Development of emphysema in Apoe-/- mice exposed to an atherogenic high-fat diet 
Emphysema is defined as a disease characterized by abnormal permanent enlargement of 
airspaces distal to the terminal bronchiole and accompanied by destruction of alveolar 
walls (Snider et al., 1985).  The effect of hypercholesterolemia on the development of 
emphysema in the Apoe-/- mice subjected to an atherogenic high-fat diet for 10 weeks was 
estimated by measuring the mean linear intercept (MLI). Morphometric analysis 
demonstrated that Apoe-/- mice fed a high-fat diet for 10 weeks developed statistically 
significant airspace enlargement compared with their controls (41.3µm vs. 32.6µm for 
the controls, p<0.0005) (Table 1). Interestingly, Apoe-/- mice fed a chow diet for 10 
weeks did not develop airspace enlargement and their MLI was lower compared to the 
MLI of Apoe-/- mice fed a high-fat diet for 10 weeks (36.8µm vs. 41.3µm, p<0.04). LDLr-
/- mice subjected to a high-fat diet for 10 weeks did not exhibit emphysematous changes 
in their lungs (Figure 1). However, LDLr-/- mice maintained on a high-fat diet for 18 
weeks developed significant airspace enlargement (29.3µm vs. 44.8µm, p<0.0009) 
(Figure 2). The measurements of alveolar surface area in the lungs of Apoe-/- and LDLr-/- 
mice confirmed the assessment of MLI (Table 1).  Apoe-/- and LDLr-/- mice had similar 
cholesterol levels when fed a Western-type diet (an average of 1118 mg/dl vs. 1167 
mg/dl). However, higher cholesterol levels have been observed in Apoe-/- mice compared 
to LDLr-/- during the period preceding the high-fat diet (an average of 818 mg/dl vs. 358 






Inflammatory response to hypercholesterolemia in the lungs of Apoe-/- mice 
To evaluate the impact of hypercholesterolemia on the inflammation in the lungs of Apoe-
/- and LDLr-/- mice, macrophages and lymphocytes were quantified in tissue sections of 
mice exposed to a Western-type diet for 10 weeks and their wild-type controls. An 
increased number of macrophages was observed in the lungs of Apoe-/- mice fed a 
Western-type diet for 10 weeks (7.72±1.33 macrophages per mm2 for the controls vs. 
10.23±1.04 macrophages per mm2 for the Apoe-/- mice, p<0.005) (Figure 2A). 
Additionally, Apoe-/- mice exhibited an increased number of lymphocytes in their lungs. 
(Figure 2B). The number of macrophages was not significantly different in the lungs of 
LDLr-/- mice fed a Western-type and chow diet for 10 weeks.  
 
Increased expression of MMP-9 and MMP-12 in the lungs of Apoe-/- mice subjected 
to a Western-type diet 
Matrix metalloproteinases (MMPs) play a crucial role in the pathogenesis of emphysema 
(Lemaitre et al., 2006; Lagente et al., 2005; Imai et al., 2001). It has been demonstrated 
that overexpression of MMP-9 in macrophages leads to the development of spontaneous 
emphysema in mice (Foronjy et al., 2008), while loss of MMP-12 protects mice from the 
development of emphysema (Hautamaki et al., 1997). Therefore, we performed 
zymography to determine the activity of MMP-9 in the lungs of Apoe-/- and LDLr-/- mice 
subjected to a Western-type diet for 10 weeks. Increased activity of MMP-9 was 
observed in the BAL fluid from Apoe-/- mice (Figure 3A). MMP-2 activity was detected 
in the BAL fluid of Apoe-/- and Apoe+/+ mice but its levels were not altered. Small increase 




type diet for 10 weeks (Figure 3B). Quantitative RT-PCR analysis confirmed elevation 
of MMP-9 on mRNA level in the lungs of Apoe-/- mice (Figure 3C). RT-PCR analysis 
revealed augmented expression of MMP-12 at the mRNA level in the lungs of Apoe-/- 
mice (n=4) compared with controls (n=4) (Figure 3C). 
 
Activation of TLR signaling pathway in response to hypercholesterolemia in the 
lungs of Apoe-/- mice 
The Toll-like receptor (TLR) pathway is activated in response to the accumulation of 
cholesterol in macrophages in Apoe-/- mice linking hyperlipidemia and TLR signaling 
(Björkbacka et al., 2004). Interleukin-1 receptor activated kinase (IRAK) is a key 
regulator in the signaling pathway of TLRs. Once activated IRAK initiates a cascade of 
signaling events ultimately leading to the induction of inflammatory genes such as 
granulocyte colony-stimulating factor (G-CSF) (Bozinovski et al., 2002; Szczepanski et 
al., 2009). To evaluate the involvement of the TLR pathway in the development of 
emphysema in Apoe-/- mice, we analyzed the expression of TLR4 and its downstream 
targets IRAK1 and G-CSF in the lungs. We did not observe changes in relative mRNA 
expression of TLR4 (RQ=1.0 ± 0.2 for Apoe+/+ vs 0.6 ± 0.3 for Apoe-/-, P=0.1; n=4 in 
each group). However, the analysis of IRAK1 and G-CSF expression revealed their 
upregulation in the lungs of Apoe-/- mice fed a Western-type diet (Figure 4A and 4B), 






TLR signaling mediates MMP-9 expression induced by hypercholesterolemic diet in 
Apoe-/- mice 
The Toll-like receptor signaling pathway is involved in various cholesterol-induced 
processes and links hypercholesterolemia with overexpression of inflammatory and 
chemokine genes. In addition, TLR signaling regulates protease expression in peritoneal 
macrophages (Sun et al., 2009). To determine whether Apoe-/- macrophages were more 
responsive to TLR activation, peritoneal macrophages from Apoe-/- mice and their 
controls were treated with activators of various TLR ligands. TLR4 increased mRNA 
expression of MMP-9 by 8-fold in Apoe-/- macrophages and by 4-fold in wild-type 
macrophages (Figure 4C). Interestingly, TLR2 and TLR3 ligands did not exhibit any 
effect on MMP-9 expression in Apoe-/- and wild-type macrophages, suggesting that the 
macrophage responsiveness was TLR4 specific (Figure 4C). 
 
Activation of ERK and JNK, downstream regulators of TLR signaling pathway, in 
the lungs of Apoe-/- mice subjected to a Western-type diet 
Mitogen activated protein (MAP) kinases such as extracellular signal-regulated kinase 
(ERK) and c-Jun N-terminal kinases (JNK) are activated by TLR signaling pathway 
(Hirata et al., 2008). Phosphorylation of ERK and JNK results in the activation of 
transcription factors regulating inflammatory genes (Hodgkinson et al., 2008). Our 
laboratory has demonstrated that phosphorylated ERK is increased in the lungs of 
patients with emphysema (Mercer et al., 2004). To determine if Apoe-/- and LDLr-/- mice 
exposed to a Western-type diet have increased levels of phospho-ERK and phospho-JNK 




expression of phospho-ERK and phospho-JNK in the lungs of Apoe-/- mice (Figure 5A 
and 5B). Interestingly, we also observed augmented expression of phospho-ERK in the 
lungs of LDLr-/- mice suggesting that activation of ERK potentially occurs early under 
hypercholesterolemic conditions (Figure 5C). In addition, we revealed that the activation 
of ERK in Apoe-/- macrophages by oxidized LDL was further increased by the addition of 





In the present study, Apoe-/- mice subjected to an atherogenic Western-type diet 
for 10 weeks developed emphysematous changes with enlargement of airspaces and 
destruction of alveolar walls.  In contrast, Apoe+/+ and Apoe-/- on a chow diet and LDLr-/- 
mice on an atherogenic diet did not manifest emphysematous changes after 10 weeks. 
Hypercholesterolemia in Apoe-/- mice resulted in lung inflammation with a significant 
increase in the number of macrophages and lymphocytes. TLR pathway activation and 
augmented expression of two major elastinolytic proteases (MMP-9 and MMP-12) was 
observed in the lungs of the hypercholesterolemic Apoe-/- mice. These potent proteolytic 
enzymes likely contributed to the observed destruction of lung extracellular matrix in the 
Apoe-/- mice. We also demonstrated that the macrophages from Apoe-/- mice were 
sensitive to TLR4 activation and hypothesize that activation of the TLR4 pathway 
secondary to hypercholesterolemia is likely responsible for the increased inflammation in 
the lung.   
Studies have suggested that obstructive pulmonary disease is a systemic disease 
rather than an independent disease state (Fabbri et al., 2007). Atherosclerosis is one of the 
leading causes of mortality in COPD (Anthonisen et al., 2002). The major hallmark of 
both pathologies is the presence of chronic inflammation with the recruitment of 
macrophages and lymphocytes (Back, 2008). It has been demonstrated that murine 
models of smoke-induced emphysema exhibit a marked increase in the number of 
macrophages and neutrophils and have augmented myeloperoxidase activity (Foronjy et 
al., 2006). Additionally, mouse models of COPD exhibit expansions of T-cells in their 




Apoe-/- mice fed only a Western-type diet for 10 weeks had both an increase in the 
number of pulmonary macrophages and lymphocytes. These aggregations of lymphocytes 
are likely secondary to changes in lipid metabolism present in Apoe-/- mice. In contrast, in 
LDLr-/- mice, emphysematous changes were observed only after 18 weeks on a high-fat 
diet. Despite exhibiting elevated cholesterol, after 10 weeks of a high-fat diet LDLr-/- 
mice did not develop emphysema and exhibited less extensive pulmonary inflammation 
compared to Apoe-/- mice. Increased susceptibility to emphysema formation in Apoe-/- 
mice compared to LDLr-/- mice may be attributed to differences in cholesterol levels and 
in cholesterol efflux. Notably, on a regular chow diet, Apoe-/- mice have higher 
cholesterol levels compared to LDLr-/- mice (an average of 818 mg/dl vs. 358 mg/dl on a 
chow diet). Apoe-/- macrophages also exhibit abnormal cholesterol efflux, which leads to 
a pathological lipid accumulation in these cells. This defect in cholesterol transport is 
caused by the deficiency of ApoE, which mainly functions to promote macrophage 
cholesterol efflux (Tall et al., 2002; Zhu et al., 1998). Interestingly, Abca1-/- and Abcg1-/- 
mice manifesting abnormal cholesterol efflux exhibit striking pulmonary inflammation 
(Baldan et al., 2008; Bates et al., 2005). In addition, increased inflammatory gene 
expression via TLR4 signaling was observed in Abca1-/- and Abcg1-/- macrophages, 
suggesting that there is a link between cholesterol efflux, lung inflammation and TLR4 
signaling (Yvan-Charvet et al., 2008). Therefore, higher cholesterol levels and possibly 
impaired cholesterol efflux likely explain why Apoe-/- mice are more susceptible to 
emphysema compared to LDLr-/- mice.  
In the present study we provide evidence for the role of TLR signaling in the 




plays a crucial role in the regulation of the immune response in atherosclerosis and in 
various lung-associated pathologies (Basu et al., 2004). It has been demonstrated that 
ablation of IL-1R1 and MyD88, downstream regulators of TLR4 signaling, in mice 
prevents lung inflammation and emphysema (Couillin et al., 2009). Furthermore, smoke-
exposed mice with targeted ablation of nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase, a potent regulator of ROS production, exhibit pulmonary 
inflammation, emphysematous changes and enhanced activation of the TLR4 signaling 
pathway (Yao et al., 2008). The TLR signaling pathway also plays an essential role in the 
development of atherosclerosis and is regulated by oxidized LDL (Choi et al., 2009). In 
addition, it has been reported that oxidized LDL-induced foam cell formation is 
positively associated with increased expression of TLR2 and TLR4 (Michelsen et al., 
2004; Xu et al., 2001), with TLR4 reducing the expression of the genes involved in 
cholesterol transport and metabolism causing a pathological lipid accumulation in 
macrophages (Castrillo et al., 2003). 
Numerous studies have shown that activation of TLR2 or TLR4 leads to the 
recruitment of IRAK1, IRAK4 and TRAF6 (Harju et al., 2001). This association can 
result in the activation of ERK and JNK, MAP kinases involved in TLR signaling. The 
present study provides evidence for TLR4 signaling activation in the lungs of Apoe-/- 
mice. Activation of this pathway is indicated by analysis of downstream targets in the 
lung, and by ex vivo experiments on elicited macrophages.  In lungs of Apoe-/- mice, we 
found upregulation of IRAK1 and activation of ERK and JNK MAP kinases, which are 
downstream targets of TLR4. We have shown previously that ERK is activated in the 




this disease (Mercer et al., 2004).  The upregulation of G-CSF, a known dowstream target 
of TLR, was also observed in the lungs of Apoe-/- mice, which probably accounts for the 
significant increase in macrophage infiltration seen in Apoe-/- mice compared to the LDLr-
/- animals.  
Increased expression of MMP-9 and MMP-12 was demonstrated in the lungs of 
Apoe-/- mice. An imbalance of proteases and antiproteases in human lung and 
endothelium is known to contribute to the development of emphysema and 
atherosclerosis, respectively (Lemaitre et al., 2006; Abboud et al., 2008; Zadelaar et al., 
2007). Several animal studies have confirmed the important role for MMPs in the 
pathogenesis of emphysema and atherosclerosis. We recently demonstrated that 
overexpression of MMP-9 in macrophages of transgenic mice caused spontaneous 
emphysema due to elastin degradation, while MMP-12 (metalloelastase) - deficient mice 
are protected from emphysema formation after smoke exposure (D’Armiento et al., 1992; 
Foronjy et al., 2008; Hautamaki et al., 1997).  Therefore, upregulation of MMP-9 and -12 
in the lungs of Apoe-/- mice ultimately contributes to the observed emphysematous 
changes, through a disruption of the lung extracellular matrix. 
Since macrophages are a major source of MMP-9, we treated elicited 
macrophages from Apoe-/- mice with various TLR ligands and demonstrated that TLR4 
ligand, but no other ligand, augmented MMP-9 expression. In addition, we observed that, 
in Apoe-/- macrophages, the activation of ERK due to oxidized LDL was increased by 
TLR4 ligand, indicating a role for TLR4 signaling in mice with abnormal cholesterol 
efflux.  These findings suggest that TLR4 signaling is responsible for ERK activation and 




emphysematous changes. In future experiments, the use of a conditional, macrophage-
specific TLR4 knockout model crossed into the Apoe-deficient background will provide 
direct evidence for the involvment of this receptor in emphysema formation.  
In summary, our study indicates that, in Apoe-/- mice fed a Western-type diet, 
severe systemic hypercholesterolemia accompanied by the abnormal cholesterol efflux 
induces pulmonary inflammation through a TLR4/ERK/MMP cascade, affecting the 
integrity of the lung. The synergistic effect of dyslipidemia and defective cholesterol 
efflux observed in atherosclerosis may also contribute to emphysema, providing a 
mechanistic link between atherosclerosis and emphysema. Our findings also add to the 
increasing evidence for the role of TLR signaling in lung diseases and in mediating 
immune responses in the lung. Therefore, we suggest that peripheral systemic changes in 
lipid transport and metabolism can ultimately lead to local lung destruction and the 
development of emphysema, a novel clinically relevant mechanism for the development 












































The incidence of chronic obstructive pulmonary disease (COPD) in patients with 
cardiovascular diseases is undervalued due to a limited knowledge regarding the 
mechanistic association between COPD and atherosclerosis. Recent studies suggest that 
the mechanism linking these two diseases can be explained by persistent systemic 
inflammation. To determine if hypercholesterolemia alters lung inflammation and 
emphysema formation, we examined the lung phenotype of rabbits at baseline and on a 
high-fat diet. The rabbits exposed to cigarette smoke were also included in the study 
population to evaluate the differences between smoke-induced and hypercholesterolemia-
induced emphysema. Airspace enlargement developed in the lungs of rabbits maintained 
on the high-fat diet for 16 weeks. Interestingly, a similar degree of lung destruction was 
observed in the lungs of rabbits exposed to cigarette smoke. An elevated number of 
macrophages accompanied by an increase in matrix metalloproteinase-1 (MMP-1) and 
matrix metalloproteinase-9 (MMP-9) expression was observed in the lungs of rabbits on a 
high-fat diet. The augmented activity of neutral sphingomyelinase and increased 
apoptosis were detected in the lungs of the rabbits on a high-fat diet suggesting that the 
molecular mechanism leading to the destruction of lung tissue in the 
hypercholesterolemic rabbits implicates ceramide signaling. Our findings indicate that 
hypercholesterolemia alone is sufficient to induce pulmonary inflammation and alveolar 






Over twelve million Americans are suffering from emphysema and its 
complications (Krishnan, 2010). Emphysema is characterized by the destruction of 
alveolar walls, ultimately leading to the irreversible enlargement of airspaces distal to 
terminal bronchioles in the lung (Sharafkhaneh, Hanania, & Kim, 2008). The most 
common comorbidities of emphysema are hypertension, diabetes, heart failure, ischaemic 
heart disease, cancer, osteoporosis, and anemia (Chatila, Thomashow, Minai, Criner, & 
Make, 2008; Mannino, Thorn, Swensen, & Holguin, 2008). The coexistence of these 
diseases clearly affects the mortality rate for emphysema. Determination of the 
underlying cause of death in patients with multiple diseases is extremely difficult, 
especially when a common risk factor such as cigarette smoking is involved. Among the 
numerous environmental and genetic risk factors contributing to the development of 
emphysema, which includes occupational exposure, air pollution, diet, alcohol 
consumption, and genetic factors, smoking is the most preventable (Fagerstrom, 2002).  
Various animal models have been developed to study the development and 
progression of emphysema (D'Armiento et al., 1992; R. Foronjy et al., 2008; Hautamaki 
et al., 1997). Mice exposed to cigarette smoke develop emphysematous changes 
accompanied by a profound pulmonary inflammation (R. F. Foronjy et al., 2005). 
Interestingly, recent studies from our laboratory demonstrate the development of a similar 
pulmonary pathology in Apoe-/- mice, a model of atherosclerosis, suggesting that there is 
a link between atherosclerosis and emphysema. The mechanisms leading to the abnormal 




imbalance between proteases and antiproteases. The excessive activity of matrix 
metalloproteinases and cathepsins is believed to be responsible for the aberrant disruption 
of the pulmonary collagen and elastin, resulting in emphysema (R. Foronjy et al., 2008; 
Shiomi et al., 2003). In accordance with this hypothesis, transgenic mice overexpressing 
matrix metalloproteinases (MMP)-1 and -9 in the lungs manifested significant 
emphysematous changes (D'Armiento et al., 1992; R. Foronjy et al., 2008). In contrast, 
mice deficient in MMP-12 were protected against smoke-induced emphysema 
(Hautamaki et al., 1997). Additionally, increased cathepsin K has been demonstrated in 
the guinea pig model of smoke-induced emphysema and in human emphysema 
(Golovatch et al., 2009). Together, these animal studies suggest that matrix 
metalloproteinases and cathepsins play a pivotal role in the development of emphysema. 
However, the murine model is not the most suited to study the proteases involved 
in human emphysema, due to differences in enzyme repertoire and physiology compared 
to humans. In particular, MMP-1, an interstitial collagenase contributing to the 
destruction of the lung extracellular matrix in human emphysema, is not present in the 
murine lung (Henriet, Rousseau, & Eeckhout, 1992; Schorpp et al., 1995). Contrary to 
murine models, the immune response and enzyme repertoire of rabbits are similar to 
those of humans (Vincenti et al., 1998; Yocum, Lopresti-Morrow, Reeves, & Mitchell, 
1999). In addition, the rabbit is an excellent model to study the pathology of 
atherosclerosis. The rabbit rapidly develops severe hypercholesterolemia, which results in 
premature atherosclerosis in response to high-cholesterol feeding (Daley et al., 1994). 
Therefore, the rabbit can be a valuable tool to study the pathology of emphysema in vivo 




In this study we sought to investigate the impact of a hypercholesterolemic diet on 
the pulmonary inflammation, proteolytic responses and the development of emphysema 







Twenty female New Zealand White rabbits weighing 1.2-1.3kg were obtained from 
Covance. The study population was divided into four groups (n=5 in each group) and 
treated as follows. The first group of rabbits was fed a high-fat atherogenic diet for 16 
weeks. The atherogenic diet contained high-fiber rabbit chow (Teklad 2031) with 4.7% 
hydrogenated coconut oil and 0.15% cholesterol (Research Diets, NJ). The second group 
of rabbits was exposed to cigarette smoke in a specially designed chamber for 4h/day 
5d/week for 16 weeks at a total particulate matter concentration of 100mg/m3. The third 
group of rabbits was challenged with both high-fat diet and cigarette smoke for 16 weeks. 
The fourth group of rabbits served as a control group and therefore was fed chow and 
exposed to room air for 16 weeks. Animals were housed at Columbia University Medical 
Center according to animal welfare guidelines. Food and drinking water were provided 
ad libitum. All animal studies were approved by the Columbia University Institutional 
Animal Care and Use Committee. Total plasma cholesterol levels were determined by a 
4-aminoantipyrine-based enzymatic assay (Wako Bioproducts, VA).   
 
Histology and immunohistochemistry 
After 16 weeks of high-fat diet and cigarette smoke, rabbits were sacrificed by carbon 
dioxide inhalation. The trachea was cannulated with a catheter secured with a silk suture. 
The lungs were lavaged first with PBS (40ml), to collect bronchoalveolar lavage (BAL) 




of rabbits was counted using a hemocytometer, and a differential analysis was conducted 
after cytospin preparation and Diff-Quick staining of the cellular pellet prepared in a 
glass slide. Cells were stained by Diff-Quick, a Romanowsky stain variant, differentiating 
monocytes, macrophages, neutrophils, and lymphocytes. Tissues were embedded in 
paraffin and sectioned (6 µm). Sections were stained with hematoxylin and eosin (H&E) 
for histological analysis. For identification and quantification of macrophages, mouse 
anti-rabbit monoclonal antibody RAM11 (DAKO) was used. For immunohistochemical 
analysis, goat polyclonal antibody for MMP-1 (R&D Systems) and goat polyclonal 
antibody for SP-A (Santa Cruz) were used. Morphometric analysis of the H&E stained 
lungs of 4 rabbits in each group was performed as previously described (R. F. Foronjy et 
al., 2006). Morphometric assessment was conducted to determine the average distance 
between alveolar walls (mean linear intercept). The degree of lung parenchymal 
destruction was determined by destructive index analysis – a microscopic point count 
technique. This analysis is performed using a transparent sheet with 50 counting points 
laid on the microscopic images from the stained lung sections. Ten histological fields 
(400X magnification) were analyzed from two separate sections from each rabbit (n=4 in 
each group) to calculate morphometric parameters.  
 
Western Blotting 
Freshly dissected lungs of rabbits (10 mg) were homogenized in 1ml of protein lysis 
buffer (PBS containing Triton X-100 0.1%), and centrifuged (14000g for 10 minutes).  








Zymography was performed to detect proteases having gelatinolytic activity, matrix 
metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). BAL samples 
obtained from the rabbits were electrophoresed in gelatin substrate gel and the gelatinases 
were visualized in a Coomassie-stained gel as clear bands. 
 
Quantitative RT-PCR 
Total RNA was extracted from two specimens of lung tissue 0.3cm3 in size with the use 
of a RNeasy kit (Qiagen). TaqMan gene expression assays were performed to assess 
gene-transcript levels with the use of an ABI Prism® 7900HT Sequence Detection 
System (Applera Corporation, Foster City, CA). Primer and probe set for Cathepsin K 
(Oc03398668_g1) were purchased from ABI. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as the housekeeping gene. Quantitative real-time 
polymerase chain reaction (qRT-PCR) analysis was performed on lung tissue from four 
animals in each group. To calculate the relative quantity (RQ) of Cathepsin K, we used 
the 2 -ΔΔCT method implemented in the software. The data are shown as the fold change in 








Apoptotic DNA strand breaks were detected in the lung sections of rabbits with the 
Roche In Situ Fluorescent Cell Death Detection Kit (Roche, Indianapolis, IN) following 
the manufacturer's protocol. Quantification of apoptotic cells was performed by counting 
the number of TUNEL-positive cells from 10 images (200X magnification) from each 
rabbit. The percentage of apoptotic cells was obtained by dividing this count by the total 
number of nuclei. Total cells were counted by using Hoecht's stain. 
 
Enzymatic Activity Determination 
Sphingomyelinase (SM) activity was measured using the Amplex Red Sphingomyelinase 
Assay Kit (Molecular Probes, Invitrogen detection technologies) following the 
manufacturer's instructions. In this assay, SM activity was monitored using a fluorogenic 
probe for hydrogen peroxide (Amplex Red reagent). Amplex Red associates with 
hydrogen peroxide, which is an ultimate product of SM activity, and generates the highly 
fluorescent product, resorufin. Hydrogen peroxide and sphingomyelinase were used as 
positive controls. The sphingomyelinase activity in the lung lysates of rabbits was 




Data are shown as mean ±SD. Unpaired two-tailed Student’s t-test analysis was 





Development of severe hypercholesterolemia in rabbits fed high-fat diet  
Rabbits maintained on a high-fat atherogenic diet for 16 weeks exhibited a dramatic 
elevation of their total cholesterol levels and developed severe hypercholesterolemia 
(1,982 mg/dl vs. 114 mg/dl for the controls) (Table 1). 
 
Increased inflammatory cell infiltration in rabbits subjected to a high-fat diet 
To evaluate the impact of hypercholesterolemia on pulmonary inflammation in rabbits, 
bronchoalveolar lavage (BAL) cell counts were performed. There was a considerable 
elevation in the total cell count of lavage from rabbits fed high-fat diet compared to their 
controls. A significant increase in the number of macrophages was detected in the lungs 
of rabbits fed a high-fat diet compared to their controls as determined by differential 
analysis (3.2x103 cells/ml vs. 0.2x103 cells/ml for the controls, p<0.009) (Figure 1). 
Macrophages were also stained with anti-RAM11 antibody, which is a specific marker of 
rabbit macrophages, and positive cells were quantified in tissue sections (114.75 cells/20 
fields vs. 16.7 cells/20 fields for the controls, p<0.004) (Figure 2A and 2B). 
Macrophages were the predominant inflammatory cell type in the lungs of rabbits fed 
high-fat diet. In addition, augmented inflammation and increase in the number of 
macrophages was observed in the lungs of smoke-exposed rabbits (110.75 cells/20 fields 
vs. 16.7 cells/20 fields for the controls, p<0.004) (Figure 2). There was also an 
impressive increase in neutrophils in the lung lavage in response to cigarette smoke 





Emphysematous changes in the lungs of rabbits due to smoke or to a fed high-fat 
diet  
Emphysema is characterized by an abnormal enlargement of airspaces distal to the 
terminal bronchiole and accompanied by destruction of alveolar walls.  The effect of 
prolonged hypercholesterolemia on the development of emphysema in rabbits was 
estimated by measuring the mean linear intercept (MLI). Morphometric analysis 
demonstrated that rabbits fed high-fat diet for 16 weeks developed statistically significant 
airspace enlargement compared with their controls (54.5µm vs. 34.5µm for the controls, 
p<0.007) (Figure 3). A destructive index analysis showed a similar pattern when 
compared to the morphometric assessment of the rabbit lungs (83% vs. 50% for the 
controls, p<0.003) (Figure 3). Cigarette smoke induced similar emphysematous changes 
in the lungs of rabbits (54.25µm vs. 34.5µm for the controls, p<0.03) (Figure 3). 
Importantly, high-fat diet in conjunction with cigarette smoke did not exacerbate 
emphysema observed in rabbits fed only high-fat diet (46.75µm vs. 54.5µm for the 
rabbits fed only high-fat diet, p<0.2). 
 
Induction of MMP-1 by cigarette smoke and high-fat diet in the lungs of rabbits 
Matrix metalloproteinase-1 is expressed in human emphysematous lungs, and our 
laboratory has identified a critical role for this protease in the disruption of lung collagen 
during emphysema (D'Armiento et al., 1992; Imai et al., 2001).  To determine the 
modulation of pulmonary MMP-1 due to a high-fat diet, lung lysates from two groups of 
rabbits were analyzed by Western blotting and ELISA. A marked increase in MMP-1 




control group (on a chow diet) (Figure 4A and 4B). Determination of the expression 
pattern of pulmonary MMP-1 using immunohistochemistry exhibited an increase in 
signal intensity in the three experimental groups compared to the controls.  MMP-1 
expression was mainly localized to the alveolar macrophages and type II epithelial cells 
(Figure 4C). We demonstrated through immunohistochemical staining that SP-A-
positive cells also express MMP-1 indicating that the expression of MMP-1 was in the 
type II epithelial cells in the lungs of the rabbits fed a high-fat diet (Figure 4C).  
 
Expression of proteases in the lungs of rabbits 
In addition to MMP-1, gelatinase B (MMP-9) has also been implicated in the 
development of emphysema. In particular we have demonstrated that MMP-9 disrupts the 
pulmonary elastin when overexpressed in macrophages of transgenic mice (R. Foronjy et 
al., 2008).  In this study, a zymography of the BAL fluids demonstrated low levels of 
MMP-9 activity in the rabbits fed high-fat diet compared to the control group, where 
MMP-9 activity was absent (Figure 4A). In contrast, casein zymography analysis 
showed that MMP-12 levels were similar in the four groups of animals (Figure 5A), 
suggesting that MMP-12 is not involved in the observed emphysematous changes in the 
rabbits. Cathepsin K mRNA expression was not altered in the lungs of 
hypercholesterolemic or smoke-exposed rabbits (Figure 5B). 
 
Alveolar cell apoptosis in the lungs of rabbits 
Apoptosis plays an important role in the pathogenesis of emphysema. Several studies 




the lungs of the patients with emphysema (Imai et al., 2005). TUNEL analysis on lung 
sections revealed a significant increase in TUNEL staining in the lungs of rabbits fed 
high-fat diet compared to their controls (0.5% vs. 0.09% for the controls, p<0.002) 
(Figure 6B and 6C). Positive and negative- control sections are shown for comparison.  
 
Increased sphingomyelinase activity in the lungs of rabbits 
Neutral sphingomyelinase (nSMase) synthesizes ceramide, which is a marker for 
apoptosis, from membrane sphingomyelin (Petrache et al., 2005). Apoptosis is a key 
process contributing to the development of emphysema. Since, activation of nSMase 
stimulates ceramide accumulation and, ultimately, apoptosis, we assessed whether the 
activity of the neutral sphingomyelinase was modulated in the lungs of rabbits fed a high-
fat diet. Interestingly, nSMase was activated in the lungs of rabbits subjected to a high-fat 
diet for 16 weeks compared to their controls (21.03 mU/mL vs. 14.05 mU/mL for the 






The present study establishes that, in rabbits, hypercholesterolemia induces 
emphysematous airspace enlargement and destruction of alveolar walls. Surprisingly, 
these morphological changes were comparable to those caused by cigarette smoke 
exposure alone.  High-fat diet-induced and smoke-induced emphysematous changes were 
both associated with pulmonary inflammation (with an infiltration of macrophages into 
the alveolar septa), augmented expression of MMP-1 (interstitial collagenase-1) in lung 
epithelial cells and macrophages, increased alveolar cell apoptosis, and elevated neutral 
sphingomyelinase activity. These observations suggest that the effects of 
hypercholesterolemia on lung inflammation and emphysema development are remarkably 
similar to the effects caused by cigarette smoke exposure. 
Numerous studies indicate that an ongoing chronic inflammatory process is a 
prominent hallmark of emphysema (Hogg et al., 2004; Roth, 2008).  In addition, it has 
been demonstrated that massive pulmonary inflammation aggravates lung injury leading 
to the formation of emphysema (Mercer et al., 2004; Saetta et al., 2001). Animal models 
of smoke-induced emphysema have shown that macrophages are the primary cell type 
contributing to the inflammatory response present in the human disease (Hautamaki et al., 
1997; Rangasamy et al., 2004). Our laboratory has also reported that macrophages are the 
predominant cell type in the BAL fluid and lung parenchyma of smoke-exposed mice (R. 
F. Foronjy et al., 2005). The present study further emphasizes the importance of 
macrophages in emphysema, with an increased number of these inflammatory cells in the 




contribution of neutrophils in the development of smoke-induced emphysema has been 
suggested by a study showing elevated activity of pulmonary myeloperoxidase, a 
neutrophil marker, in smoke-exposed mice (R. F. Foronjy et al., 2006).  In the present 
study, smoke-exposed rabbits also exhibited a higher number of neutrophils in their 
lungs, compared to the air-exposed controls, further suggesting a possible 
interrelationship among neutrophil influx, cigarette smoke and emphysema. However, the 
number of pulmonary neutrophils was not changed in rabbits fed a high-fat diet, and 
therefore these cells likely do not play an important role in the formation of emphysema 
caused by hypercholesterolemia. 
Our present study not only demonstrates that hypercholesterolemia induces 
airspace enlargement in rabbits, but also shows that these pathological changes are 
comparable with those resulting from chronic exposure to cigarette smoke. Both 
treatments induced a 50% increase in the mean linear intercept in lungs of rabbits, which 
is significantly higher than that seen in smoke-exposed guinea pigs and mice (R. F. 
Foronjy et al., 2005; Golovatch et al., 2009). This finding suggests that rabbits are more 
sensitive to the development of emphysema compared to other animal models.  Higher 
susceptibility to emphysematous development in rabbits could be explained, in part, by 
differences in their enzyme repertoires compared to other species. In particular, rabbits, 
contrary to rodents, possess a homologue for MMP-1, an interstitial collagenase playing 
an important role in emphysema development in humans (Vincenti et al., 1998; Yocum et 
al., 1999). Clinical and animal studies have demonstrated that MMP-1 contributes to the 
disruption of the lung extracellular matrix, leading to the development of emphysema 




lungs of transgenic mice, human MMP-1 digests type III collagen fibrils, ultimately 
causing emphysema. In humans, MMP-1 is detected in emphysematous lungs, mainly in 
epithelial cells and macrophages, but not in normal lungs, and its expression is induced 
by cigarette smoke in small airway epithelial cells through the MAP kinase ERK (Imai et 
al., 2001; Mercer et al., 2004; Segura-Valdez et al., 2000). Here we demonstrate elevated 
expression of MMP-1 in lung epithelial cells and macrophages of rabbits, either fed with 
an atherogenic diet or exposed to cigarette smoke, suggesting that this protease 
participates in the observed emphysematous changes. It is not clear how MMP-1 is 
induced in the lungs of hypercholesterolemic rabbits, but studies have demonstrated that 
cholesterol loading triggers MMP-1 expression in macrophages in vitro, suggesting that a 
similar mechanism may be involved in the alveolar macrophages of rabbits in vivo 
(Ardans, Economou, Martinson, Zhou, & Wahl, 2002). The contribution of MMP-1 in 
rabbit emphysema will have to be further investigated, using specific inhibitors of this 
enzyme in conjunction with a high-fat diet or smoke exposure.  In addition to MMP-1, 
other studies have suggested a role for MMP-9 in the development of emphysema (R. 
Foronjy et al., 2008; Ohnishi et al., 1998). In the present study however, MMP-9 
expression was only slightly elevated in the lungs of rabbits either fed high-fat diet or 
exposed to cigarette smoke, suggesting that MMP-9 may play a minor role in the 
observed pathological changes in rabbits.  
Alveolar cell apoptosis has been associated with oxidative stress, inflammation, 
and proteolytic imbalance, and contributes to the initiation and progression of 
experimental and human emphysema (Kasahara et al., 2000; Tuder, Petrache, Elias, 




IFN-γ or deficient in VEGF underscored the importance of apoptosis in the pathogenesis 
of emphysema (Tang et al., 2004; Zheng et al., 2005). Our laboratory has reported 
increased alveolar epithelial and endothelial cell apoptosis in the lungs of patients with 
emphysema (Imai et al., 2005). The present study shows that emphysema in rabbits 
exposed to a high-fat diet or to smoke is associated with increased apoptosis. This 
observation suggests that hypercholesterolemia has a comparable effect to cigarette 
smoke in the induction of alveolar epithelial cells death, a mechanism that likely 
contributes to the destruction of alveoli. The molecular mechanisms responsible for 
apoptosis in the lungs of hypercholesterolemic rabbits are not known, but interestingly 
we detected elevated levels of neutral sphingomyelinase, an enzyme generating ceramide, 
in the lungs of rabbits either fed a high-fat diet or exposed to cigarette smoke. Patients 
with emphysema manifest elevated levels of ceramide in their lungs, and it has been 
shown that inhibition of ceramide synthesis prevents alveolar cell apoptosis, oxidative 
stress and emphysema in mice (Petrache et al., 2005).  Our present study suggests that 
elevated sphingomyelinase activity secondary to a high-fat diet or to smoke may 
exacerbate ceramide signaling, leading to an increase in alveolar apoptosis in rabbits. 
Furthermore, ceramide signaling is a known activator of MMP-1 expression via MAPK 
pathways, such as ERK1/2, SAPK/JNK, and p38 (Reunanen et al., 1998). Therefore, in 
addition to apoptosis, ceramide signaling may also be involved in MMP-1 upregulation 
observed in the emphysematous lungs of rabbits. 
Surprisingly, rabbits challenged with both chronic cigarette smoke exposure and a 
high-fat diet did not develop more severe emphysematous airspace enlargement 




suggests that cigarette smoke and a high-fat diet do not act in a synergistic way on the 
inflammatory response of the lung, and further underlines the complexity of emphysema 
formation and development.  
Our present work emphasizes the importance of hypercholesterolemia and 
concomitant pulmonary inflammation in the formation of emphysema in rabbits.  Studies 
using animal models and clinical data on human patients have shown that inflammation is 
a critical event in the development of emphysema. This study provides further evidence 
for the link between hypercholesterolemia, pulmonary inflammation, and destruction of 
alveolar walls.  In particular, enhanced number of alveolar macrophages, elevated MMP-
1, and increased apoptosis may constitute critical and common events in the development 
of the disease secondary to hypercholesterolemia and cigarette smoke exposure. Further 
investigation on the relationships between alterations in cholesterol metabolism, lung 
tissue proteolysis and inflammation is required. An enhanced understanding of the link 
between cholesterol-induced inflammation and alveolar destruction may provide novel 


































 Chapter 5 






It is widely recognized that a greater comprehension of the molecular mechanisms 
leading to alveolar destruction would aid in the diagnosis and treatment of emphysema.  
Emphysema is a complex disease influenced by various genetic and environmental 
factors, and the research work displayed in this thesis contributes to our understanding of 
this pathology. 
The studies presented in this thesis provide novel and interesting insight into the 
pathogenesis of emphysema and its molecular and cellular determinants. In chapter two, 
we demonstrate that increased expression of cathepsin K in the lungs of smoke-exposed 
guinea pigs contributes to the degradation of the pulmonary extracellular matrix, which 
ultimately results in the development of emphysema. The selection of this animal model 
for our research is explained by the fact that the development of emphysema in guinea 
pigs exhibits several similarities to that of the human disease.  In particular, guinea pigs 
develop pulmonary morphological and physiological changes when exposed to the same 
concentrations of cigarette smoke as humans (Wright & Churg, 2002).  
Surprisingly, and despite all these advantages, this animal model has been used 
extensively in asthma, but not in COPD research.  In this second chapter, we not only 
characterize the guinea pig as a model of smoke-induced emphysema, but we also 
examine the effect of cigarette smoke exposure on protease expression, MAPK signaling 
and generation of emphysematous lesions.  We identify that smoke-induced emphysema 
in this model is associated with decreased alveolar type III collagen. This finding is 
important, since our laboratory has demonstrated that the disruption of this major type of 




interstitial collagenase (MMP-1) in the lungs (Shiomi et al., 2003). Other studies also 
reported decreased amounts of collagen associated with emphysematous alveolar 
destruction in smoke-exposed guinea pigs (Selman et al., 1996; Wright & Churg, 1995). 
Since only a few enzymes are capable of degrading fibrillar collagens, we first examined 
the expression of collagenolytic MMPs in the lungs of smoke-exposed guinea pigs. 
Interestingly, we did not detect changes in the expression of these proteases, leading us to 
examine another important class of proteases, the cathepsins, which exhibit 
collagenolytic activity. Together with the MMPs, cathepsins have been shown to be 
involved in the pathogenesis of emphysema. In particular, mice overexpressing IFN – γ 
have increased expression of several cathepsins (B, D, H, L and S) in their lungs (Wang 
et al., 2000). We discovered that the expression and activity of cathepsin K was increased 
in the lungs of smoke-exposed guinea pigs compared to air-exposed controls. Using 
human samples, we found that cathepsin K was also significantly elevated in the lungs of 
patients with emphysema, suggesting for the first time that this protease contributes to the 
pathological disruption of the lung extracellular matrix in emphysema. 
Prior to our discovery, cathepsin K was shown to contribute to another lung 
disease, idiopathic pulmonary fibrosis (IPF) (Buhling et al., 2004; Srivastava et al., 
2008). Since cathepsin K possesses a collagenolytic activity, it is hypothesized that its 
role in IPF is to attenuate the excessive deposition of pulmonary collagen, which is a 
prominent characteristic of fibrosis (Srivastava et al., 2008). Our data suggest that, in 
addition to pulmonary fibrosis, cathepsin K also participates in the remodeling of lung 
collagen in human emphysema, and provide evidence for a new mechanism of 




Research in our laboratory has shown that the ERK, MAP kinase, is activated in 
human emphysema, inducing the expression of MMP-1, an enzyme critical in pulmonary 
collagen disruption (Mercer et al., 2004). In our guinea pig model, we also demonstrate 
increased phosphorylation of pulmonary ERK due to smoke (Golovatch et al., 2009), 
where it likely contributes to the induction of inflammatory genes.  However, the impact 
of ERK activation on cathepsin K expression remains to be examined. In addition to 
ERK, other signaling pathways activated by cigarette smoke may contribute to the 
inflammatory response associated with the destruction of lung parenchyma.  In particular, 
it has been shown that acute exposure to cigarette smoke causes infiltration of neutrophils 
and activation of NF-kB signaling in the lungs of guinea pigs (Nishikawa et al., 1999).  
The study presented in the third chapter focused on the effects of 
hypercholesterolemia and abnormal cholesterol efflux on the lung extracellular matrix. 
The lung phenotype of two murine models of atherosclerosis was examined for possible 
pathological changes, and we found that Apoe-/- mice fed a high-fat diet for 10 weeks 
develop emphysematous airspace enlargement, accompanied by alveolar wall destruction. 
In contrast, Ldlr-/- mice were less susceptible to emphysematous changes compared to 
Apoe-/- mice: pathological disruption of the lung parenchyma was observed in Ldlr-/- mice 
after 18 weeks on a high-fat diet, but no changes were seen after 10 weeks on a the diet.  
These data suggest that the development of emphysema in Apoe-/- mice is not only due to 
hypercholesterolemia, but also to specific properties of Apolipoprotein E. For instance, 
absence of ApoE has been shown to impair cholesterol efflux in macrophages (Tall, 
Costet, & Wang, 2002; Zhu et al., 1998). As a consequence, pulmonary macrophages in 




an increased accumulation of cholesterol when fed a high-fat diet, leading to emphysema 
formation. The critical functions of ApoE in reverse cholesterol transport may therefore 
explain why the Ldlr-/- mice didn’t develop the same emphysematous changes observed 
in the Apoe-/- animals. 
To investigate the mechanisms leading to emphysema in Apoe-/- mice, we 
analyzed the expression of proteases that are believed to contribute significantly to the 
disruption of the lung extracellular matrix. We observed that the expression of MMP-9 
(gelatinase B) and MMP-12 (macrophage elastase) was elevated in the lungs of Apoe-/- 
mice fed with a high-fat diet.  Both MMP-9 and MMP-12 can efficiently digest elastin, 
which is a major component of the lung extracellular matrix (R. Foronjy et al., 2008; 
Hautamaki et al., 1997). Overexpression of MMP-9 in transgenic macrophages induces a 
progressive airspace enlargement in mice, accompanied by a decrease in alveolar elastin 
(R. Foronjy et al., 2008). Clinical studies identified increased MMP-9 and MMP-8 levels 
in the BAL fluids from patients with subclinical pulmonary emphysema, further 
suggesting a role for MMP-9 in this disease (Betsuyaku et al., 1999). An important role 
for MMP-12 in the pathogenesis of emphysema has also been proposed, since MMP-12-
deficient mice are protected against smoke-induced airspace enlargement (Hautamaki et 
al., 1997). Therefore, in our study, we assert that increased MMP-9 and MMP-12 activity 
likely contributes to the alveolar destruction observed in Apoe-/- mice fed Western-type 
diet.  
TLR4 signaling plays an important role in atherosclerosis (den Dekker, Cheng, 
Pasterkamp, & Duckers, 2010). Our work suggests that there is also an association 




pathways responsible for the emphysematous changes observed in Apoe-/- mice fed a 
high-fat diet and found evidence that activation of TLR4 signaling contributes to the 
destruction of alveolar septa in these mice. Evidence for TLR4 signaling includes 
increased IRAK1, activation of downstream targets, ERK and JNK, and high levels of G-
CSF expression in the lungs. Moreover, in vitro experiments on Apoe-/- macrophages 
demonstrated that activation of TLR4 signaling by a specific antagonist induced MMP-9 
expression. As mentioned above, ERK activation and MMP-9 expression in the lung are 
two characteristics of emphysematous development.  Our data suggest for the first time a 
link between hypercholesterolemia, TLR4 activation, and the development of 
emphysema.   
In atherosclerosis, activation of the TLR4 signaling has been shown to reduce the 
expression of major genes involved in cholesterol efflux in macrophages, ultimately 
causing pathological lipid accumulation in these inflammatory cells (Castrillo et al., 
2003). Therefore, in addition to MAP kinases and MMP-9 activation, TLR4 signaling 
could be important in pulmonary inflammation by inhibiting macrophage cholesterol 
efflux, although a contribution of this mechanism to lung disease has not been 
demonstrated yet. 
In the fourth chapter, to further understand the genetic and molecular aspects of 
emphysema, we used rabbits to study the development of this disease due to smoke or to 
a high-fat diet. Contrary to mice and guinea pigs, rabbits express MMP-1, an enzyme that 
is believed to be critical in human emphysema (Vincenti et al., 1998; Yocum et al., 
1999). Clinical and animal studies have demonstrated that MMP-1 contributes to the 




1992; Imai et al., 2001). Since mice do not possess this proteolytic enzyme, genetic 
modifications are required to investigate the role of MMP-1 in alveolar destruction 
(D'Armiento et al., 1992). Rabbits naturally express a homologue for human MMP-1 in 
their lungs and for this reason they potentially constitute a more relevant experimental 
model to elucidate the mechanisms responsible for the formation of emphysema.   
Our studies demonstrate that rabbits maintained on a Western-type diet for 16 
weeks developed emphysematous changes similar to those observed in rabbits on a chow 
diet exposed to cigarette smoke for the same period of time. Surprisingly, rabbits 
challenged with both cigarette smoke and a high-fat diet developed emphysematous 
airspace enlargement but its severity was not altered. This observation suggests that 
cigarette smoke affects the lung extracellular matrix in a complex fashion that involves a 
broad spectrum of proteolytic degradation, possibly followed by connective tissue protein 
resynthesis or reorganization. In addition, emphysematous changes in the rabbits were 
accompanied by an elevation of the number of macrophages, which is a characteristic of 
the inflammatory response contributing to the development of emphysema. In addition, 
we detected increased MMP-1 expression in the lungs of rabbits either exposed to 
cigarette smoke or fed a high-fat diet, suggesting that this collagenase contributes to the 
observed destruction of the lung parenchyma. This protease has been a major focus of our 
laboratory for a significant period of time. Initially, it had been shown in our laboratory 
that mice overexpressing MMP-1 in their lungs develop progressive airspace enlargement 
due to type III collagen digestion. Later, Imai et al. identified that patients with 
emphysema have increased MMP-1 expression in their lungs, and Mercer et al. 




to MMP-1 secretion. The induction of MMP-1 in the epithelial cells of the rabbit model 
allows us to investigate the molecular signaling mechanisms that lead to alterations in the 
epithelium in vivo. Even though the mechanisms leading to increased expression of 
MMP-1 in the lungs of rabbits fed a high-fat remain to be elucidated, our study further 
suggests an important role for hypercholesterolemia and high-fat diet in the pathogenesis 
of emphysema, leading to a similar inflammation as the one induced by cigarette smoke.  
Emphysematous changes in the rabbits were accompanied by an increase in the 
number of alveolar apoptotic cells.  To further understand the mechanisms leading to 
lung damages and apoptosis in rabbits, we measured pulmonary sphyngomyelinase 
activity in these animals. Sphyngomyelinase activity generates ceramide, which is 
involved in pulmonary apoptosis of alveolar epithelial and endothelial cells and in 
emphysema (Petrache et al., 2005). In the fourth chapter, we demonstrate an increase in 
sphingomyelinase activity in the lungs of rabbits exposed to cigarette smoke or fed a 
high-fat diet, compared to the controls. These data suggest that ceramide signaling might 
be activated in the lungs in response to both cigarette smoke and to high-fat diet.  An 
inducer of oxidative stress, hydrogen peroxide, leads to the activation of ceramides and 
apoptosis (Goldkorn et al., 1998), and it is therefore possible, that in our rabbit model, 
ceramide signaling is activated by an oxidative stress resulting from either cigarette 
smoke or a high-fat diet.  In conclusion, our data suggest that elevated sphingomyelinase 
activity due to cigarette smoke or a high-fat diet may lead to an increase in ceramide 
signaling, contributing to alveolar apoptosis and emphysematous airspace enlargement in 
the lungs of rabbits (Medler et al., 2008). However, the precise role of sphingomyelinase 




In the past, studies involving animals and human subjects have had a major 
impact on our understanding of disease processes and on the development of drug 
therapies. Elucidation of biochemical pathways that mitigate inflammation resulted in the 
development of phosphodiesterase and leukotriene receptor inhibitors (Celik et al., 2005; 
Price, Chisholm, Ryan, Crockett, & Jones). Phosphodiesterase inhibitors prevent the 
breakdown of cAMP, thus, decreasing the activity of inflammatory cells (Bourne et al., 
1974; Price et al., 2010). Leukotriene receptor antagonists inhibit bronchoconstriction 
and decrease inflammatory cell infiltration (Celik P, Sakar A, Havlucu Y, 2005). While 
these are effective treatments for pulmonary inflammation, other therapies targeting 
proteolytic imbalance, oxidative stress or alveolar apoptosis have not been developed. In 
addition, the investigation of various genetic factors contributing to COPD susceptibility 
may help to determine the causes of the disease and explain why not all smokers develop 
COPD. 
The work presented in this thesis deepens our comprehension of the molecular 
and cellular determinants of emphysema and provides us with valuable knowledge about 
the factors contributing to the formation of the disease pathology. This research improves 
our understanding of the adverse effects of cigarette smoking and high-fat diet on the 
lung inflammation, proteolytic responses and the development of emphysema. However, 
further investigation about the relationships between alterations in cholesterol 
metabolism, lung tissue proteolysis and inflammation is required. Specifically, an 
enhanced understanding of the relationships between cholesterol-induced inflammation 





The pathology of emphysema was characterized in three different animals: guinea 
pigs exposed to smoke, Apoe-/- mice on a high-fat diet, and rabbits exposed to smoke or 
fed a high fat-diet. All exhibited airspace enlargement and the destruction of alveolar 
walls, which are the major characteristics of emphysema. The development of 
emphysema in these animals is associated with increased inflammation, upregulation of 
proteases and activation of cellular signaling pathways. Despite all these similarities, 
each experimental model reveals distinct inflammatory cell profile, enzyme repertoire 
and signaling cascade involved in the development of emphysema.  
Inflammation accompanied by the recruitment of macrophages into the alveolar 
septa is observed in all our animal models.  In addition to macrophages, the lungs of 
Apoe-/- mice exhibited increased number of lymphocytes, which may play a key role in 
the inflammatory response leading to the development of emphysema in these mice.  
Infiltration of neutrophils was observed in the lung parenchyma and bronchoalveolar 
lavage of smoke-exposed rabbits, but not in rabbits fed a high-fat diet. These findings 
indicate that inflammatory responses resulting from hypercholesterolemia and smoke 
exposure are not identical, although they result in the same degree of emphysematous 
changes. 
Examination of inflammatory pathways demonstrated activation of MAP kinases 
in guinea pigs exposed to smoke and in Apoe-/- mice fed a high-fat diet. In particular, 
ERK was elevated in both models, suggesting a key role for this kinase in emphysema 
development, as observed in the human disease.  In Apoe-/- mice, TLR4 likely plays a key 




the role played by TLR4 in emphysema formation in the other animal models (guinea 
pigs and rabbits) remains to be elucidated. 
Elevated protease activity in the lungs is a common feature of the animal models 
characterized in this study, suggesting that proteolytic injury contributes to the 
development of emphysema in these models.  In particular, our study reveals that, in 
every model we used, smoke exposure or a high-fat diet results in an elevation of 
pulmonary MMP-9, an enzyme participating in elastolysis (Foronjy, 2005). However, the 
collagenolytic response varies between the species.  In guinea pigs, chronic exposure to 
smoke does not modulate the expression of collagenolytic MMPs, such as MMP-1 and 
MMP-13.  In this model, smoke-induced disruption of the pulmonary collagen is likely 
due to increased cathepsin K activity, a potent collagenase also expressed in human 
emphysema. In rabbits, cathepsin K activity was not modulated by smoke or a high-fat 
diet, but these treatments induced interstitial collagenase (MMP-1) expression. The 
cellular origin of these collagenolytic enzymes also diverged between guinea pigs and 
rabbits. Cathepsin K in guinea pigs is expressed in macrophages, while MMP-1, similarly 
to human emphysema, is induced in type II pneumocytes. These data suggest that the 
collagenolytic response in the lungs secondary to hypercholesterolemia or smoke 
exposure is highly dependent on the animal species. MMP-1 is a key player in the 
pathogenesis of human emphysema, and its induction in type II pneumocytes of rabbits 






In conclusion, our analysis of mice, guinea pigs, and rabbits as experimental 
models demonstrates that these animals are all useful to discover new pathways leading 
to lung dysfunction and emphysema.  Since rabbits develop emphysema, express MMP-1 
in type II pneumocytes and naturally develop atherosclerosis when fed a high-fat diet, 
these animals are better suited to explore the link between atherosclerosis, 
hypercholesterolemia, and emphysema. Rabbits are also an appropriate model to 
understand the precise mechanisms leading to emphysematous changes secondary to 
cigarette smoke exposure.  
 
Table 1. Summary of the present study. Animal models of emphysema. 
Animal models of 
emphysema 














































































The studies presented in this thesis demonstrate that, in animal models, 
hypercholesterolemia and cigarette smoking can induce inflammation and matrix 
proteolysis, leading to the development of airspace enlargement. This work not only adds 
significantly to the field of emphysema research, but also raises numerous interesting 
questions that will need to be investigated, in order to fully understand the pathogenesis 
of this disease. 
In the third chapter, the development of emphysema was identified in Apoe-/- mice 
fed a high-fat diet for 10 weeks. In Ldlr-/- mice, emphysematous changes were observed 
after 18 weeks on the diet, but not after 10 weeks. Through extensive analysis, TLR4 
signaling was established as a principal molecular mechanism leading to the pathological 
changes in the lung architecture of Apoe-/- mice on a high fat diet. However, the status of 
TLR4 signaling was determined only in Apoe+/+ on a chow compared to Apoe-/- mice on 
an atherogenic diet.  In future experiments, we will further investigate the status of TLR4 
activation in lungs of Apoe+/+, Apoe-/-, and Ldlr-/- mice.  These mice will be fed a chow or 
an atherogenic diet for ten to eighteen weeks, and pulmonary TLR4 signaling will be 
examined.   
To further ascertain the role of macrophage TLR4 signaling in the pathogenesis of 
emphysema in Apoe-/- mice, the use of a conditional knockout model for this receptor will 
be required. Our laboratory has recently developed a transgenic mouse model that 
specifically expresses Cre recombinase in tissue macrophages (Morishita et al., 
manuscript in preparation). These transgenic mice have already been crossed into the 




flanked by Lox sequences, will be generated and crossed into our macrophage-specific 
Cre expressing, Apoe knockout model. This conditional knockout model will allow us to 
ascertain the role of macrophage TLR4 in the development of emphysema in Apoe-/- 
mice. In particular, resistance to emphysematous changes in this model would 
demonstrate that TLR4 plays a central role in lung disease in hypercholesterolemic Apoe-
/- mice. 
In the fourth chapter, the pathogenesis of emphysema was investigated in the 
lungs of rabbits either fed a high-fat diet or exposed to cigarette smoke. These studies 
determined that airspace enlargement could potentially result from the upregulation of 
MMP-1 in the alveolar type II cells, as shown by immunohistochemistry.  In vivo 
expression of MMP-1 mRNA in type II pneumocytes can be further assessed by in situ 
hybridization of lung sections.  Ex vivo studies involving alveolar type II cells and 
macrophages isolated from rabbit lungs will aid in establishing the molecular 
mechanisms leading to increased expression of MMP-1 (and other inflammatory 
molecules) secondary to smoke or to a high-fat diet.  Changes in the expression of 
proteolytic enzymes, in particular collagenases (MMP-1, -13, -8, and -14) and MMP-9, 
and proinflammatory cytokines that are critical in emphysema, such as IL-13, will be 
examined in these isolated cells in culture, using quantitative PCR, zymography, 
Western-blotting, and ELISA.  These in vitro studies will also focus on transduction 
pathways, including ceramide, TLR, and MAP kinase signaling.  In particular, Western 
blotting will determine the levels of activated ERK in these cells.  Since we have 
demonstrated that ERK is regulating MMP-1 expression in human lung epithelial cells 




will be assessed using specific chemical inhibitors, such as PD98059 or siRNA, followed 
by the analysis of MMP-1 expression.  TLR signaling will be also investigated, since 
TLR4 may be crucial in the development of emphysema in Apoe-/- mice. Treatment with 
various commercially available TLR ligands and inhibitors will allow us to determine the 
role of these receptors in the modulation of MMP-1 expression in either alveolar type II 
cells or alveolar macrophages in culture. In addition to TLRs, the potential contribution 
of ceramide signaling to the development of emphysema in rabbits should also be 
assessed, since we have shown an elevation of N-sphingomyelinase in the lungs after 
exposure to smoke or to a high fat diet.  Therefore, the levels of ceramides and their 
derivatives in the lungs of hypercholesterolemic and smoke-exposed rabbits will be 
evaluated. Individual species ceramides will be measured by liquid chromatography and 
mass spectrometry.  Moreover, rabbit alveolar type II cells and macrophages in culture 
will be treated with ceramide and the consequences of this treatment on MMP-1, 
proteases, and cytokines expression will be assayed using real-time PCR and ELISA. 
Studies involving the inhibition of ceramide pathway, using siRNA, GW4869 (an 
inhibitor of N-sphingomyelinase), and fumonisin B1 (a ceramide synthase inhibitor), will 
further clarify the role of ceramide signaling in the development of emphysema 
secondary to smoke or to a high-cholesterol diet. Another useful model to study the 
effects of hypercholesterolemia on lung disease is the Watanabe heritable hyperlipidemic 
(WHHL) rabbit. These rabbits have deficient LDL receptor activity due to a deletion in 
the LDL-binding domain (Yamamoto et al., 1986), leading to hypercholesterolemia 
(average plasma cholesterol levels of 700 to 1200 mg/dl) and to the development of 




used as a model to study human familial hypercholesterolemia and have also helped in 
the development of drugs aimed at lowering cholesterol levels and preventing 
atherosclerosis (Shiomi and Ito, 2009). Presence of emphysematous changes and 
pulmonary inflammation in these rabbits would further demonstrate the existence of a 
link between hypercholesterolemia and emphysema formation. Moreover, the WHLL 
rabbits could be useful to determine the effects of cholesterol-lowering drugs, such as 
statins, on the development of emphysema. 
Since we have demonstrated that hypercholesterolemic and smoke-exposed 
rabbits exhibit increased expression of MMP-1 in their lungs, the studies demonstrating 
the direct link between this enzyme and emphysema formation in a rabbit model are 
necessary. The contribution of MMP-1 to rabbit emphysema can be further investigated, 
using specific inhibitors of MMP-1 activity in conjunction with high-fat diet or smoke 
exposure.  In addition, studies blocking upstream regulators of MMP-1 gene expression, 
such as TLR4 or ceramide, can represent an alternative means of treating protease-driven 
emphysema. The absence of emphysematous changes in the rabbits fed high-fat diet or 
exposed to cigarette smoke would further clarify the role of MMP-1 in the development 
of emphysema in rabbits. 
Finally, further epidemiological studies are required to better understand the 
effect of hypercholesterolemia on pulmonary inflammation and lung function in humans. 
These studies will determine the key molecular players associated with the correlation 
between obesity, cholesterol levels, and a decline in lung function in non-smokers 
demonstrated in our study. A direct clinical correlation between cigarette smoke induced 




interest in the human disease. Clinical studies can also evaluate ceramide signaling in the 




Figure 1. Potential mechanism for the development of emphysema secondary to a 
high-fat diet or cigarette smoke. Hypercholesterolemia (due to a high-fat diet) and/or 
exposure to cigarette smoke induce an inflammatory response in the lung, characterized 
by an accumulation of alveolar macrophages. At the molecular level, 
hypercholesterolemia and/or exposure to cigarette smoke cause the activation of 
sphingomyelinase, leading to ceramide signaling, followed by a cascade involving TLR4, 
and ERK and JNK MAP kinases. This signaling cascade results in the induction of 
apoptosis and in the release of collagenolytic cathepsin K and MMP-1 and elastolytic 
MMP-9. Digestion of pulmonary elastin and collagen, together with increased apoptosis, 
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